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a2M                           Alpha-2 macroglobulin 
*a2M                         Activated alpha-2 macroglobulin 
AEP                             anterior entopeduncular area 
AMPA                         α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
BACE1                         Beta-secretase 1 
BSA                             Bovine serum albumin 
cAMP                          cyclic adenosine monophosphate  
CC1/APC                    Anti-adenomatous polyposis coli                             
CC                               Corpus Callosum  
CD91                           Cluster of differentiation 91 
CGE                             Caudal ganglionic eminence  
CNS                             Central nervous system  
CNTF                           Ciliary neurotrophic factor 
Cre                              Cre Recombinase 
Ctx                               Cortex 
DIV                              Days in vitro 
DMEM                        Dulbeccos’s modified eagle medium 
DNA                             Deoxyribonucleaic acid  
DTT                              Dithiothreitol 
EAE                              Experimental autoimmune encephalomyelitis  
EBSS                             Earle’s balanced salt solution 
EdU                              5-Ethynyl-2’-deoxyuridine 
FBS/FCS                       Fetal bovine serum/fetal calf serum 
FGF                              Fibroblast growth factor  
 xi 
GFP                              Green fluorescent protein 
GPR17                         G protein coupled receptor 17 
HRP                              Horseradish peroxidase 
LGE                               Lateral ganglionic eminence  
LRP1                             Low-density lipoprotein receptor related protein 1  
LRP2                             Low-density lipoprotein receptor related protein 2 
MBP                             Myelin basic protein  
MS                                Multiple Sclerosis 
MyRF                            Myelin regulatory factor 
NAC                              N-acetyl cysteine  
NeuN                            Neuronal Nuclear Antigen 
NG2                              Neural/glial antigen-2  
NT3                               Neurotrophin 3  
OL                                  Oligodendrocyte 
ON                                 Optic nerve  
OPC                               Oligodendrocyte progenitor cells  
OLIG1                            Oligodendrocyte transcription factor-1  
OLIG2                            Oligodendrocyte transcription factor-2  
PDGF-AA                       Platelet derived growth factor-AA                   
PDGFRa                        Platelet derived growth factor receptor alpha  
PDGFRb                        Platelet derived growth factor receptor beta  
PDL                                Poly D-lysine 
pMN                              Primary motor neuron 
RAP                                Receptor Associated Protein 
RNA                                Ribonucleic acid  
 xii 
Shh                                 Sonic hedgehog  
SVZ                                 Subventricular zone 
T3                                   Triodothyronine 
TFEB                              Transcription factor EB 
VGCC                             Voltage gated calcium channel  
VLDL                              Very low-density lipoprotein   





Oligodendrocyte progenitor cells (OPCs) are found throughout the adult central nervous 
system (CNS), where they continually differentiate into oligodendrocytes.  This feature of OPC 
behaviour makes them an attractive target for remyelination enhancing therapies aimed at 
treating demyelinating diseases such as Multiple Sclerosis.  However, for this approach to 
work, further information is needed about the role of specific cell-surface receptors in 
directing OPC behaviour in the adult CNS.  One cell surface receptor that is highly expressed 
by OPCs, but rapidly down regulated as they differentiate into oligodendrocytes, is the low-
density lipoprotein receptor related protein (LRP1).  LRP1 is a member of the low-density 
lipoprotein receptor family, and it is capable of signalling in a variety of ways.  To investigate 
the role that LRP1 plays in modulating adult OPCs, I conditionally deleted Lrp1 from OPCs in 
the healthy and demyelinated adult mouse CNS.  In the healthy CNS, OPCs without Lrp1 had 
an increased rate of proliferation and gave rise to a larger number of newborn 
oligodendrocytes overtime.  However, the myelinating profile of individual new 
oligodendrocytes was unchanged. Following cuprizone induced demyelination control mice 
had larger demyelinated lesions when compared to Lrp1-deleted mice, suggesting that the 
blockade of LRP1 signalling by OPCs could enhance remyelination.    By studying the effect of 
Lrp1 deletion and the ligand activation of LRP1 on OPC behaviour in vitro, I determined that 
the effect of LRP1 on OPC proliferation was likely to be secondary to the inhibitory effect of 
LRP1 on OPC differentiation.  These data suggest that suppressing LRP1 signalling may be 
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Chapter 1: Introduction 
1.1 Glia  
The central nervous system (CNS) is a highly organised structure that consists of the brain, 
optic nerve and spinal cord, and contains a variety of specialised cell types.  These cells include 
neurons and glia [astrocytes, oligodendrocytes (OLs), microglia, oligodendrocyte progenitor 
cells (OPCs) and neural stem cells].  Historically, the study of neurons has largely dominated 
the field of neuroscience research, with the glial cells (glia - meaning glue), being thought of 
simply as support cells.  However, in recent years researchers have developed a greater 
understanding of the functional diversity of glia, and have shown that they play a crucial role 
in maintaining normal CNS function.  In particular, OPCs have been shown to generate new 
OLs throughout life.  
 
1.2 Oligodendrocyte precursor cells (OPCs) 
 
OPCs, also known as NG2 glia or O-2A progenitors, were first discovered in primary cell 
cultures derived from perinatal rat optic nerve (Stallcup, 1981; Raff et al., 1983), and were 
later found to be present in primary cultures derived from adult rat optic nerve (ffrench-
Constant and Raff, 1986).  Although their morphology can vary between development and 
adulthood as well as between brain regions, OPCs are normally highly ramified cells with 
processes extending away from their cell bodies in all directions. They can be identified by the 
expression of platelet derived growth factor receptor alpha (PDGFRa) (Pringle and Richardson, 
1993) or the chondroitin sulphate proteoglycan NG2 (Zhu et al., 2008) (Figure 1), however 
pericytes, associated with the CNS vasculature (and inflammatory microglia) also express NG2 
(Fukushi et al., 2004; Zhu et al., 2016). OPCs also express the transcription factor OLIG2, which 













Figure 1. Markers of the oligodendrocyte lineage 
OPCs can be identified by the expression of PDGFRa and NG2. As they differentiate, they lose 
expression of these markers and begin expressing oligodendrocyte precific markers such as 
ASPA and CC1. Myelinating oligodendrocytes can be indetified by the expression of MBP. All 












1.3  OPC origins 
OPCs are first generated during embryonic development in mice and around gestational week 
9 in humans (Jakovcevski et al., 2009).  During embryonic development, OPCs are produced 
from the neuroepithelial stem cells, also known as radial glial cells (Noll and Miller, 1993; 
Pringle and Richardson, 1993).  In the spinal cord, OPC generation commences at embryonic 
day 12.5 (E12.5) in mice, and E16 in rats, from stem cells located in the ventral region of the 
neuroepithelium, known as the pre motor neuron (pMN) domain (Noll and Miller, 1993; 
Richardson et al., 2006).  The pMN domain is named for its role prior to OPC generation, when 
the stem cells instead generate the spinal cord motor neurons.  It is defined by the expression 
of two transcription factors, OLIG1 and OLIG2 (Zhou et al., 2000), both of which are highly 
expressed in OPCs and necessary for their production and differentiation (Dai et al., 2015).  
OLIG1/2 expression in the pMN domain is induced by a gradient of ventrally secreted sonic 
hedgehog (Shh).  Examination of Olig1/2 knockout mice confirmed the importance of these 
transcription factors for motor neuron and OPC generation.  In the absence of OLIG1/2, stem 
cells in the pMN domain instead form V2 interneurons and astrocytes (Zhou and Anderson, 
2002).  Shortly after they first appear, OPCs begin migrating in all directions until they are 
evenly spread throughout the spinal cord grey and white matter by E18 in rats (Pringle and 
Richardson, 1993).  It is estimated that approximately 85% of all spinal cord OLs originate from 
pMN, with other domains such as the P3 domain, ventrally adjacent to pMN (Richardson et 
al., 2006), and more dorsal domains (dP3 and dP6) producing the rest (Rowitch and Kriegstein, 
2010).  The dorsal neuroepithelial stem cells are influenced by different spatiotemporal 




Like spinal cord OPCs, forebrain OPCs have multiple origins, which were discovered by cre-lox 
fate mapping (Kessaris et al., 2005).  Kessaris et al. (2006) found that PDGFRα+ OPCs are 
generated and migrate in three distinct waves.  The initial wave of OPCs is produced from 
Nkx2.1 expressing  stem cells in the ventral telencephalon, specifically the medial ganglionic 
eminence (MGE) and the anterior entopeduncular area (AEP) at E12.5 in mice.  These cells 
migrate along blood vessels (Tsai et al., 2016) from their ventral origins to populate all regions 
of the developing brain, including the developing cortex, which they reach at ~E18 (Tekki-
Kessaris et al., 2001).  The next wave of OPCs is initiated at E15.5 from the Gsh2 expressing 
stem cells in the lateral and caudal ganglionic eminence (LGE and CGE) (Kessaris et al., 2005), 
and migrates to combine with the first wave in the cortex.  The third and final wave of OPCs 
originates from the Emx1 expressing neuroepithelial stem cells underlying the developing 
cortex.  These newly born OPCs migrate dorsally, and can be found throughout the cortex and 
corpus callosum (CC) just after birth.  Unexpectedly, the earliest OPCs produced by Nkx2.1 
cells are lost shortly after birth, particularly from the cortex and CC (Kessaris et al., 2005), and 
the purpose of these temporary OPCs is still unknown.  By postnatal day 13 (P13), ~80% of OL 
lineage cells in the CC are derived from the cortical ventricular zone, and the remainder from 
the MGE/LGE (Tripathi et al., 2011).   
 
1.4 OPC heterogeneity 
The idea that the OPC population is heterogeneous stemmed from the discovery of the mixed 
developmental origins.  However, diphtheria toxin A (DTA) ablation of  a specific 
subpopulation of OPCs didn’t change to the number of OL lineage cells at P12 or the level of 
myelination in adult mice, suggesting that OPCs from other origins can compensate for the 
loss of one population (Kessaris et al., 2005).  Additionally,   RNA-sequencing data has failed 
to identify any difference in the gene expression profile between OPCs born from separate 
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germinal niches (Marques et al., 2018).  More recently however, Winkler et al (2018) reduced 
the number of dorsally-derived OPCs in embryonic mice, by conditionally deleting 
Smoothened (Smo), a Sonic Hedgehog (Shh) signalling effector, and found that OL number 
was normal at early postnatal ages, due to compensation from ventrally-derived OPCs and the 
proliferation of the remaining dorsal OPCs, yet the grey matter OPC population did not fully 
recover. 
 Furthermore, only a subset of OPCs express the G Protein Coupled  Receptor 17 (GPR17) in 
the adult CNS (Lecca et al., 2008) and OPCs expressing GPR17 are less likely to differentiate 
into OLs (Viganò et al., 2016), suggesting that not all OPCs are equivalent. As GPR17 expressing 
OPCs do not localise to a specific CNS region, but are dispersed throughout the grey and white 
matter of the CNS, Vigano et al (2016) concluded that these OPCs act as a reserve pool, so that 
following white matter injury they can rapidly proliferate in order to sustain the OPC 
population.  
 
1.5 OPCs in the healthy adult central nervous system  
Following OPC generation and migration during development, OPCs in the adult CNS form a 
lattice like network and are evenly spread throughout the grey and white matter (Figure 2). 
They  make up ~5% of the total number of cells and are the most proliferative cell type present 
in the adult CNS (Dawson, 2003).  This network of cells is maintained by homotypic repulsion, 
most likely achieved via interactions between adhesion molecules on the filopodial extensions 
that are yet to be determined (Hughes et al., 2013).  In mice, adult OPCs proliferate and 
differentiate at a slower rate than developmental OPCs (Psachoulia et al., 2009; Young et al., 
2013), and in the adult human brain, the rate of generation of OLs is  ~100 times lower than 
in rodents and is more pronounced in the grey matter (Yeung et al., 2014).  However, following 













Figure 2. Distribution of OPCs in the adult CNS 
 
Coronal brain section of pseudo-coloured YFP labeled OPCs from adult Pdgfrα-CreERTM:: 
Rosa26YFP mice at 30 days post tamoxifen showing their uniform distribution throughout the 














repair (Franklin et al., 1997; Levine and Reynolds, 1999; Chari and Blakemore, 2002; Zawadzka 
et al., 2010).   
 
1.5.1 More than just oligodendrocyte progenitors  
 
While the best characterised function of OPCs is the lifelong addition of new OLs, they also  
regulate a number of other important functions within the adult CNS, [reviewed by (Pepper 
et al., 2018)].  For example, recent work has shown that OPCs interact with microglia and keep 
them in a homeostatic state (Liu and Aguzzi, 2019), and the ablation of OPCs from the adult 
rat brain can lead to neuronal loss from the hippocampus due to sustained microglial 
activation and inflammation (Nakano et al., 2017).  Furthermore, OPC dysfunction may play a 
role in the pathology of mental illness, as the genetic ablation of OPCs from the prefrontal 
cortex of young adult mice leads to the development of anxiety and depressive like behaviours 
within 7 days, due to abnormal neuronal glutamate neurotransmission and astrocytic 
glutamate uptake (Birey et al., 2015).  As OPCs perform a number of critical functions in the 
adult CNS, understanding the signalling pathways that influence OPCs behaviour could prove 
beneficial for the treatment of a variety of neuropathologies.  
 
1.6 Oligodendrocytes  
 
OLs are myelinating cells that facilitate rapid and reliable action potential conduction and 
provide trophic support to the underlying axons (Lee et al., 2017).  Oligodendrogenesis occurs 
during postnatal development (Zhu et al., 2008; 2011),  whereby developmental OPCs divide 
symmetrically to produce two OPCs or two OLs, or asymmetrically to produce one OPC and 
one OL  (Zhu et al., 2011).  OPCs differentiating into OLs go through two distinct phases, a 
highly ramified premyelinating phase then a mature myelinating form characterised by the 
elaboration of myelin internodes. During differentiation, PDGFRa and NG2 expression is lost 
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and the OLs acquire others markers such a APC/CC1, ASPA and myelin associated proteins 
such as myelin basic protein (MBP) and cyclic nucleotide phosphodiesterase (CNPase) (Figure 
1). It is important to note that not all OPCs that differentiate go on to form myelinating OLs, 
as large number of the newly differentiated OLs undergo apoptosis during development and 
adulthood (Trapp et al., 1997; Kougioumtzidou et al., 2017).  This pathway is in part due to 
Transcription Factor EB (TFEB), a key component of the programmed cell death pathway, as 
knocking  out TFEB  from OPCs  results in more myelination by preventing apoptosis, but also 
results in regions that are not normally myelinated becoming myelinated  (Sun et al., 2018).  
 
1.6.1 Activity and myelination   
 
There are a number of signalling pathways that can enhance OPC differentiation and 
myelination, including neurotransmission. OPCs receive direct synaptic input from neurons 
and express glutamate and GABA receptors, as well as voltage-gated sodium and voltage-
gated calcium channels (Bergles et al., 2000; Lin and Bergles, 2004; De Biase et al., 2010; Cheli 
et al., 2015; Pitman et al., 2019).  This allows OPCs to sense the activity of axons and previous 
studies have shown that neuronal activity leads to increased oligodendrogenesis and 
myelination in vitro (Demerens et al., 1996; Wake et al., 2011)  and in vivo (Li et al., 2010; 
Gibson et al., 2014; Mitew et al., 2018; Cullen et al., 2019).  Furthermore, sensory (Barrera et 
al., 2013) or social deprivation (Makinodan et al., 2012) has a negative impact on myelination. 
However, neurotransmission is not always necessarily required for myelination, as OLs in 
culture can myelinate synthetic fibres and paraformaldehyde-fixed axons (Rosenberg et al., 
2008; Lee et al., 2012), suggesting that signals from axons are not essential for the formation 
of a myelin internodes.  Additionally, the myelinating capacity of OLs is subject to intrinsic 
regulation as spinal cord derived OLs elaborate longer internodes than cortical OLs when 




1.6.2 Oligodendrocyte generation in adulthood   
 
Even after myelin is laid down during development, some neurons within the adult CNS 
remain unmyelinated or sparsely myelinated (Tomassy et al., 2014).  With >20% of all OLs in 
the mouse corpus callosum being generated after 7 weeks of age (Rivers et al., 2008).  OL 
addition to the adult mouse CNS increases OLs density up until around 2 years of age and is 
associated with the continuous filling in of unmyelinated segments of partially myelinated 
axons. After two year of age, the level of myelin decline and signs of myelin degeneration 
become apparent (Hill et al., 2018). In humans, myelin degeneration has been shown to 
correlate with the development of age related cognitive decline and the progression of 
neurological disorders (Bartzokis, 2004; Safaiyan et al., 2016; Hill et al., 2018).   
 
1.7 Myelin internode formation 
 
Premyelinating OLs in contact with axons extend  their cytoplasm to spirally wrap around the 
axon to form the layers of the myelin sheath (reviewed by (Snaidero and Simons, 2014).  Most 
OLs generate somewhere between 10 and 60 myelinating processes, with each process only 
myelinating one axon.  Given the large number of internodes formed by just one OL, the 
process of internode formation must be highly controlled and live imaging studies in zebrafish 
have shown that following initial contact, OLs make all their myelin sheaths within 5 hours 
and only sheath retractions are made after that time (Czopka et al., 2013). Control of sheath 
extension or retraction is controlled by calcium signalling as a result of local neuronal activity 
(Baraban et al., 2018; Krasnow et al., 2018). Along a single zebrafish axon, mature myelin 
internodes increase in length to compensate for an increase in body length, and ablation of a 
single internode leads to neighbouring internodes temporarily increasing in length until a new 
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internode can be made (Auer et al., 2018).  Neuronal activity can also influence the number 
and length of individual internodes (Mensch et al., 2015; Cullen et al., 2019), for example, 
stimulating the mouse brain with an electromagnetic field was shown to increase internode 
length after 14 days of stimulation (Cullen et al., 2019).   The exact mechanisms that govern 
the initiation of myelin internode formation from OPCs or OLs is likely regulated by a number 
of intrinsic and extrinsic factors (reviewed by (Osso and Chan, 2017).  
 
1.8 Oligodendrocyte lineage cells in the damaged CNS  
 
1.8.1 Differentiation block  
 
Damage to CNS myelin can have severe adverse effects on CNS function and is a hallmark of 
neurodegenerative diseases such as Multiple Sclerosis (MS).  In response to demyelination,  
adult OPCs can rapidly migrate to regions of demyelination and facilitate repair [reviewed by 
(Franklin and ffrench-Constant, 2008)]. In the mouse, OL generation from parenchymal OPCs 
within the CNS is accompanied by new OPC addition from neural stem cells in the 
subventricular zone (SVZ) (Menn et al., 2006; Xing et al., 2014).  Once at a demyelinated 
region, OPCs will expand and differentiate into OLs where they can remyelinate.  
In people with MS, remyelination is often incomplete.  Chronic MS lesions often contain OPCs 
(Wolswijk, 2002) and some premyelinating OLs (Chang et al., 2002), however, these cells fail 
to terminally differentiate into myelinating OLs (Kuhlmann et al., 2009; Fancy et al., 2010), 
and this pathological situation has been termed differentiation block. Differentiation block, in 
part, results from a lack of MyRF expression, as MyRF deletion from OPCs does not impact the 
recruitment of OPCs to the site of lysolethicin-induced demyelination but does impair their 
capacity to terminally differentiate (Duncan et al., 2017).  Changes in myelin biochemistry may 
also prevent remyelination and be a significant driver of MS progression, as the citrullination 
of MBP prevents the myelin sheath compacting  and contributes to myelin instability (Beniac 
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et al., 2000), and protein hypercitrullination is a hallmark of MS (Bradford et al., 2014).  
However, conditional deletion of peptidylarginine deiminase 2 (PAD2) from mouse OPCs, an 
enzyme responsible for citrullination of MBP, reduces myelination by impairing in OPC 
differentiation (Falcao et al., 2019).  
 
1.8.2 The remyelinating capacity of existing oligodendrocytes 
 
While it has long been accepted that OPCs generate new OLs in response to an injury, and that 
these OPC-derived OLs are the cells responsible for remyelination (Franklin and Ffrench-
Constant, 2008, Zawadzka et al., 2010), a growing body of evidence suggests that pre-existing 
OLs may also play a significant role in restoring myelin and consequently nervous system 
function (Duncan et al ., 2018, Yeung et al., 2019, Bacmeister et al,. 2020)  By analysing 14C 
incorporation by cells within the post-mortem brain, it was possible to determine that in the 
most aggressive cases of MS, new OLs were added to the brain, however, in the majority of 
MS cases, OLs present within remyelinated MS lesions were born during early life, not during 
adulthood, over the course of the disease (Yeung et al., 2019).  By analysing the myelin 
internodes of OLs in the brains of large animal models, including cats and non-human 
primates, it was also possible to show that individual cells elaborated internodes that 
resembled developmental myelin as well as internodes that resembled reparative myelin 
(Duncan et al., 2018).  Recently, Bacmeister et al. (2020) showed that surviving OLs in the CNS 
of cuprizone-treated mice were also able to contribute to remyelination, if the mice were 
subjected to a motor learning task following partial remyelination.  They also showed that 
surviving OLs preferentially added new myelin sheathes to denuded or previously myelinated 
axon regions even after motor learning was complete, while newborn OLs preferentially 
myelinated previously unmyelinated axons (Bacmeister et al., 2020).  These data suggest that 
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remyelination may best be achieved by promoting myelin repair from surviving OLs, as well as 
increasing OL generation from OPCs.  
 
1.8.3  Disease specific oligodendrocyte lineage cells  
 
A growing body of evidence now suggests that OL lineage cells play an active role in 
immunomodulation.  Under inflammatory conditions, OPCs have been shown to upregulate 
MHC class I and class II proteins (Falcao et al., 2018), which enhances the proliferation and 
survival of invading immune cells.  Cells of the OL lineage can also upregulate their expression 
of immunomodulatory chemokines (Balabanov et al., 2007) and pro-inflammatory cytokines 
such as IL-17A (Tzartos et al., 2008). Deleting Act1 from NG2 glia, a key component of the IL-
17 receptor signalling pathway, dramatically reduces the severity of experiment autoimmune 
encephalomyelitis (EAE) in mice (Kang et al., 2013).  In humans with MS, different subtypes of 
OLs have been identified by single nucleus RNA sequencing (Jäkel et al., 2019), suggesting that 
OLs have different functional states within MS lesions and normal appearing white matter. 
These recent findings suggest that cells of the OL lineage play an important role in the 
regulation and propagation of the inflammatory environment.   
 
1.9 Sequencing databases of oligodendrocyte lineage cells 
 
Identifying candidate proteins that may be regulating OPC and OL function has become more 
streamlined with the availability of microarray and RNA sequencing databases.   Microarray 
analysis comparing transcriptome of major CNS cell types was able to compare differentially 
expressed transcripts between OPC and mature OLs.  Unsurprisingly, some of the main 
differentially expressed transcripts were PDGFRa and NG2, which we know are highly 
expressed in OPCs but not mature OLs (Cahoy et al., 2008).  Another highly differentially 
expressed transcript is Lrp1, which was found to be 31.7 fold enriched in OPCs compared to 
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mature OLs (Cahoy et al., 2008).  Over the years, additional databases have been published 
and the Lrp1 transcript has been shown to be consistently expressed in OPCs but not in OL 
(Figure 3) (Zhang et al., 2014; Hrvatin et al., 2018).  However, the role of LRP1 in OPCs is yet 
to be elucidated.   
 
1.10  Low Density Lipoprotein Receptor Related Proteins 1 and 2 
 
The LDL receptor family is a large family of multi-ligand receptors.  Core family members 
include the: LDL receptor; very low density lipoprotein (VLDL) receptor (Brown and Goldstein, 
1986), LDL receptor related protein (LRP1), also known as CD91 and the α-2-macroglobulin 
receptor (Binder et al., 2000; Liu et al., 2000; Marschang et al., 2004); LRP2, also known as 
GP330 and Megalin (Saito et al., 1994); LRP5 (Hey et al., 1998); LRP6 (Brown et al., 1998), and 
LRP8, also known as Apolipoprotein Receptor-2 (Riddell et al., 1999).  Each family member is 
a single-pass transmembrane receptor, containing two or more extracellular cysteine-rich 
complement type repeats, which act as ligand binding domains (Daly et al., 1995).   
At 600kDa, LRP1 and LRP2 are the largest and most promiscuous members of the LDL 
receptor family.  Transcription of the Lrp1 gene can be activated by a number of transcription 
factors including sterol regulatory element binding protein 2 (Llorente-Cortes et al., 2006), 
hypoxia-induced factor1α (Castellano et al., 2011), and nitric-oxide dependent transcription 
factors (Grana et al., 2012), but is negatively regulated by naturally occurring antisense 
transcripts, inversely coded within exons 5 and 6 of the Lrp1 gene (Yamanaka et al., 2015).  
The Lrp1 gene codes for a precursor protein that binds to the receptor associated protein 
(RAP), a chaperone that occupies the ligand binding domains of the precursor (Rudenko et 
al., 2002) to prevent the binding of other ligands (Willnow et al., 1995), and ensure its correct 
folding in the endoplasmic reticulum (Bu and Marzolo, 2000; Croy et al., 2003) (Figure 4).  RAP 












Figure 3. Lrp1 RNA expression within the oligodendrocyte lineage 
 
RNA sequencing database comparing the transcriptional profile of major CNS cells types 
shows Lrp1 mRNA is highly express in OPCs but not mature oligodendrocytes.  FPKM = 



























Figure 4. LRP1 maturation and structural organisation 
 The LRP1 protein is first synthesised as a precursor protein in the endoplasmic reticulum 
where it is bound by the receptor associated protein (RAP) chaperone.  It is then transported 
to the trans-Golgi network where the low pH causes RAP to dissociate.  The protease Furin 
then cleaves the LRP1 precursor at the RX(K/R)R consensus sequence to generate a large α 
chain (515kDa) and a smaller β chain (85kDa)  which remain non covalently linked as they 
shuttled to the cell membrane where they are imbedded as one functional unit.  The α chain 
contains 4 ligand binding domains (red) that interact with a large number of ligands.  The β 
chain contains a small extracellular region, a transmembrane region which anchors the LRP1 
protein within the plasma membrane, as well as two dileucine (LL, green) motifs and two 
asparagine-proline-x-tyrosine (NPxY, blue) motifs, where the distal motif is contiguous with a 
tyrosine-x-x-leucine (YxxL, pink) motif which interact with intracellular adaptor proteins and 







involves the proximal NPXY motif in the intracellular domain of the protein (Reekmans et al., 
2009).  In the trans-Golgi network, the low pH of the secretory pathway causes protonation 
of the histidine residues in domain 3 of RAP (Lee et al., 2006), triggering its dissociation from 
the LRP1 precursor (Bu et al., 1995; Rudenko et al., 2002).  The protease Furin then cleaves 
the LRP1 precursor at the RX(K/R)R consensus sequence, to generate a large α-chain (515kDa) 
and a smaller β-chain (85kDa) (Willnow et al., 1996b).  The two fragments remain non-
covalently linked on their way to the cell membrane, where they are embedded as one 
functional unit, comprising mature LRP1 (Figure 4).  LRP2 is similarly chaperoned by RAP 
(Czekay et al., 1997), and also contains an RX(K/R)R consensus sequence, but there is no 
evidence that LRP2 undergoes intracellular proteolytic processing prior to its insertion into 
the plasma membrane (Saito et al., 1994). 
1.11 Soluble LRP1 and LRP2 
 
Once LRP1 is inserted into the plasma membrane, the soluble extracellular domain (sLRP1) 
can be cleaved from the cell surface by enzymes such as the beta-site APP cleaving enzyme 1 
(BACE1) (Arnim et al., 2005) and metalloproteinase (Selvais et al., 2011) (Figure 5).  sLRP1 
contains the α-chain and a 55kDa fragment of the β-chain (Quinn et al., 1999), and can be 
detected in plasma and cerebral spinal fluid (Quinn et al., 1997; Liu et al., 2009).  Similarly, 
soluble fragments of LRP2 have been shown to be released from cultured choroid plexus 
epithelial cells, and can be detected in cerebral spinal fluid (Spuch et al., 2015).  LRP1 and 
LRP2 can then undergo intra-membrane proteolysis mediated by γ-secretase, in either the 
plasma or endosomal membrane (Shah et al., 2013), to liberate an intracellular fragment 
which reportedly enters the nucleus (May, 2002a; Biemesderfer, 2006) (Figure 5a).  The 
physiological function of soluble LRP fragments in normal neural cell development is poorly 
understood, but they have the potential to bind LRP ligands and prevent them from binding 






Figure 5.  Signalling mechanisms employed by LRP1 
a. The extracellular domain of LRP1 can be shed following cleavage by Beta-site APP cleave 
enzyme 1 (BACE1) and metalloproteinases (MP) producing a soluble form of LRP1 (sLRP1). 
sLRP1 is thought to bind ligands of LRP1 to prevent binding to full length LRP1. Additionally, 
the intracellular domain can be cleaved by γ-secretase and is thought result in changes to 
gene transcription. b. Ligand binding to LRP1 can result in receptor internalisation.  Once 
internalised, the ligand/receptor complex can be processed in a multitude of ways, including 
degradation by lysosomes or rescretion via trancytotic and recycling vesicles. c. Specific 
regions on the intracellular region of LRP1 may interact with a number of adaptor proteins 
and modulate intracellular signalling mechanisms eg Disabled 1 (Dab1) has been shown to 
interact with the NPXY motifs which may recruit non receptor tyrosine kinases such as Src and 
Abl.  d. Activation of LRP1 by specific ligands has been shown to transactivate other receptors 
such as tyrosine receptor kinase A (TrkA), which can then activate downstream signalling 






























1.12 LRP1 and LRP2 as mediators of endocytosis 
 
While the proteolytic processing of these receptors is becoming increasingly well understood, 
LRP1 and LRP2 remain best known for their role in mediating endocytosis (Figure 5b).  
Following ligand binding to mature LRP1 in the plasma membrane, it was originally believed 
that the two NPXY motifs of the cytoplasmic domain interacted with the endocytic machinery 
to mediate rapid clathrin-dependant endocytosis of the receptor-ligand complex, as has been 
previously shown for other members of this receptor family (Chen et al., 1990).  However for 
LRP1, the YXXL motif and the distal di-leucine motif independently mediate endocytosis, and 
the NPXY motifs are not required (Li, 2000).  The rate of endocytosis is regulated by cAMP-
dependent Protein Kinase A, which constitutively phosphorylates LRP1, predominantly at 
serine 76 of the cytoplasmic tail (Li et al., 2001).   
Like LRP1, LRP2 has two intracellular NPXY domains (Saito et al., 1994), however unlike LRP1, 
the distal NPXY motif of LRP2 has been shown to interact with the phosphotyrosine-binding 
domain of Disabled-2 (Oleinikov et al., 2000), a clathrin-associated sorting protein, to mediate 
endocytosis (Nagai, 2005; Traub, 2009; Shah et al., 2013).  Interestingly, endocytosis does not 
occur during mitosis, due to the phosphorylation of Disabled-2, which removes it from the cell 
surface, so that it no longer co-localizes with clathrin, and cannot mediate this process (Chetrit 
et al., 2011).  LRP2-directed endocytosis may still occur via clathrin-independent pathways, 
instead relying on the small GTPase Arf6 and Caveolin 1 (Wolff et al., 2008; Bento-Abreu et 
al., 2009).  Furthermore, LRP1- and LRP2-mediated endocytosis can be influenced by the 
expression of miR199a and miR199b family members, which regulate the expression of a 
number of genes critical for clathrin-dependent and clathrin-independent endocytosis 
(Aranda et al., 2015).  Following endocytosis, the extracellular beta-propeller regions of LRP1 
and LRP2 facilitate ligand dissociation (Jeon et al., 2001), so that the ligands and receptors can 
be differentially sorted in early endosomes.   
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The mechanisms regulating the recycling of LRP1 back to the plasma membrane are not fully 
characterised, and may vary between cell types.  However, it is known that this process 
requires binding of the adaptor protein sorting nexin 17 to the first NPXY domain of LRP1 in 
early endosomes (Donoso et al., 2009; Farfán et al., 2013), so that LRP1 is recycled back to the 
cell surface in approximately 30 minutes (Ko et al., 1998).  In early endosomes, the first NPXY 
domain of LRP2 instead binds the phosphotyrosine-binding domain of autosomal recessive 
hypercholesterolemia (ARH) (Nagai et al., 2003), a clathrin-associated sorting protein that 
couples LRP2 to the dynein motor complex (Lehtonen et al., 2008), and transports it from the 
sorting endosomes to the endocytic recycling compartment (Shah et al., 2013).  The 
constitutive phosphorylation of LRP2 by GSK3β is also involved in directing LRP2 to the 
endocytic recycling compartment, from which it is slowly recycled to the plasma membrane 
(Yuseff et al., 2007).   
But what happens to the internalized ligand?  LRP1 and LRP2 have been shown to bind 
upwards of 40 different ligands, many of which are structurally and functionally unrelated, 
and the list is always evolving (Spuch, 2017).  They both have four LDL receptor homology 
regions which are the extracellular ligand-binding domains (Herz and Strickland, 2001; 
Marzolo and Farfán, 2011), and bind common ligands including tissue-type plasminogen 
activator (Willnow et al., 1992; Bu et al., 1993; Grobmyer et al., 1993; Lin et al., 2016), 
apolipoprotein E, lactoferrin (Willnow et al., 1992; Croy et al., 2003), and metallothioneins I 
and II (Ambjørn et al., 2008), however not all ligands have been shown to bind both receptors.  
α2-macroglobulin is a high affinity ligand for LRP1 (Hanover et al., 1983; Marynen et al., 1984), 
and like prion protein has only been demonstrated to bind to LRP1  (Parkyn et al., 2008), while 
transthyretin (Sousa et al., 2000), and the complex of vitamin D with the vitamin D binding 
protein have only been shown to bind LRP2 (Nykjaer et al., 1999).  Once endocytosed, ligands 
may be degraded in lysosomes, re-secreted from recycling endosomes, or trafficked in 
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transcytotic vesicles from the apical to the basolateral membrane (or visa versa) before being 
secreted (Willnow et al., 2012) (Figure 5b).   
1.13 LRP1 and LRP2 Intracellular Signal Transduction 
 
The true complexity of LRP1 and LRP2 signalling lies in the fact that these receptors not only 
trigger endocytosis, but influence signal transduction.  Upon ligand binding, the NPXY motifs 
can function as docking sites for intracellular adaptor proteins.  LRP1 can bind cytosolic ligands 
in a phosphorylation-dependent manner, via two di-leucine motifs and one YXXL motif in the 
intracellular domain.  For example, the adaptor proteins Disabled-1 and FE65 can bind to the 
NPXY motifs of LRP1, to recruit and activate non-receptor tyrosine kinases such as Src and Abl 
to the cytoplasmic tail (Trommsdorff et al., 1998) (Figure 5c), allowing the receptor to 
transduce an intracellular signal, or form signalling hubs through the binding of co-receptors 
(Spuch, 2017) (Figure 5d).  A number of co-receptors of LRP1 have been identified, including 
platelet-derived growth factor receptor beta (PDGFRβ) (Boucher et al., 2002; Loukinova, 
2002), tropomyosin-related kinase receptor A (Shi et al., 2009), amyloid precursor protein 
(Pietrzik, 2004) and insulin-like growth factor 1 receptor (Woldt et al., 2011). These 
associations increase the number of intracellular pathways by which distinct LRP ligands may 
elicit their effects.   
1.14 LRPs as Regulators of Nervous System Development 
 
Despite the large number of common ligands, and the structural similarities that exist 
between LRP1 and 2, the two genes are not functionally redundant during development.  Both 
the Lrp1 and Lrp2 single knockout mice have severe developmental phenotypes.  Lrp1 
knockout blastocysts fail to implant, and therefore do not develop into embryos (Herz et al., 
1992).  Lrp2 knockout mice are mostly embryonic lethal, presenting with defects including a 
cleft palate, failure to form an olfactory bulb, and fusion of the forebrain hemispheres, 
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resulting in a single ventricle (holoprosencephaly) (Willnow et al., 1996a).  The small number 
of Lrp2 knockout mice that survive until birth experience severe vitamin D3 deficiency, as the 
reabsorption of vitamin D and the vitamin D binding protein from the kidney proximal tubule 
is LRP2-dependant, but die of respiratory failure (Willnow et al., 1996a; Nykjaer et al., 1999).  
Human mutations in Lrp2 are known to cause faciooculo-acoustico-renal syndrome / Donnai-
Barrow syndrome, an autosomal recessive disorder associated with disrupted brain 
formation, including agenesis of the corpus callosum (Kantarci et al., 2007).   
The very early developmental defect observed in the Lrp1 knockout mouse, and the gross 
neural phenotype of Lrp2 knockout mouse, do not allow us to investigate the importance of 
these receptors for the functioning of individual neural cell types.  However, a variety of 
expression studies performed alongside knockdown and conditional knockout approaches, 
have demonstrate that both receptors mediate ligand endocytosis and intracellular signalling 
in a number of immature neural cell types.  LRP1 is more widely expressed in the CNS than 
LRP2, being detected in mature neurons, particularly those of the entorhinal cortex, 
hippocampus (Wolf et al., 1992) and cerebellum (Bu et al., 1994), and all CNS glia (Gaultier et 
al., 2009).  In contrast, LRP2 expression is restricted to the apical surface of the neural tube, 
and subsequently to the forebrain, optic stalk, and otic vesicle during development (Assémat 
et al., 2005; Spoelgen, 2005).  In the CNS of adult mice, LRP2 is predominantly expressed by 
cells of the choroid plexus (Chun et al., 1999) and ependymal cells (Gajera et al., 2010), but 
has also been detected in oligodendrocytes of the spinal cord (Wicher et al., 2005).  The 
expression patterns of LRP1 and LRP2 are largely spatially and temporally distinct, reflecting 
their different roles in CNS regulation. 
1.15 LRP1 and LRP2 as Regulators of Neural Stem Cell Function 
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1.15.1 Neural Stem Cells in the Developing and Adult CNS 
 
The early neural tube is a pseudostratified epithelium composed of neuroepithelial precursor 
cells.  These early neural stem cells divide symmetrically, expanding their population, before 
switching to include asymmetric divisions that generate neuroblasts.  This switch coincides 
with a change in gene expression, as the neuroepithelial precursor cells transition into radial 
glial stem cells, which comprise two molecularly distinct subgroups in the developing human 
brain, corresponding to those in the outer subventricular zone, and those in the ventricular 
zone (Pollen et al., 2015).  Following neuroblast generation, radial glia switch to glial 
generation starting with the production of OPCs and concluding with the production of 
astrocytic precursors (Kessaris et al., 2008).  Towards the end of development a subset of 
radial glial stem cells adopt a more astrocytic gene expression profile and give rise to the adult 
neural stem cells (Young et al., 2007).   
In adulthood neural stem cells reside in two key niches, the subventricular zone of the lateral 
ventricles and the dentate gyrus of the hippocampus, where they proliferate to generate 
intermediate progenitor cells, and ultimately neuroblasts (O'Rourke et al., 2014).  Neural stem 
cells in the subventricular zone also produce a small number of OPCs under normal 
physiological conditions (Young et al., 2010).  The behaviour of neural stem cells (and their 
intermediate progenitors) is highly controlled by mitogenic and morphogenic signalling.  While 
key ligands and receptors for these pathways are well described, the role of LRP1 and LRP2 in 
these pathways has only recently been elucidated.  
1.15.2 LRPs as Regulators of Cell Fate Specification  
 
LRP1 and LRP2 have both been shown to facilitate the internalisation of the potent 
morphogen, sonic hedgehog (McCarthy, 2002; Morales, 2006; Capurro et al., 2012), a finding 
that has provided insight into the significant neurodevelopmental defects observed in patients 
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and mice lacking normal functioning Lrp2 (Willnow et al., 1996a; Spoelgen, 2005; Kantarci et 
al., 2007).  LRP2 is expressed by neuroepithelial cells, on the apical side of the neural plate, as 
early as E7.5 in the mouse.  After neural tube closure at E9.5, LRP2 expression becomes 
increasingly restricted to the midline, ultimately being localised to the clathrin-coated pit 
regions of the apical cell membrane, clustered at the base of the primary cilium (a cellular 
organelle essential to sonic hedgehog signalling) (Choudhry et al., 2014), and in the sub-apical 
endosomes of the radial glia (Christ et al., 2012).  At E8 sonic hedgehog is produced by cells of 
the axial mesoderm (the notochord and prechordal plate), and by E8.5 its expression expands 
to include the radial glia at the ventral midline of the rostral diencephalon.  This expansion 
does not occur in Lrp2 knockout embryos, as LRP2 is required for the radial glia to bind and 
sequester sonic hedgehog as it diffuses, regulating morphogen presentation to the neural 
stem cells (Christ et al., 2012).   
Once sonic hedgehog is bound to LRP2 it can also bind its receptor patched-1, and the complex 
undergoes clathrin-mediated endocytosis (Christ et al., 2012).  All components can then be 
found within early endosomes and recycling endosomes, but do not appear to be targeted to 
the lysosome for degradation.  The internalisation of patched-1 by LRP2, results in activation 
of the effector smoothened, leading to changes in gene transcription mediated by the gli 
transcription factors.  Therefore, in the absence of LRP2, radial glia show reduced expression 
of the sonic hedgehog target genes gli1 and six3 (Christ et al., 2012).  The loss of sonic 
hedgehog and gli3-mediated transcriptional repression has secondary consequences for 
neural development, including aberrant bone morphogenic protein 4 expression in the dorsal 
forebrain (Spoelgen, 2005; Fuccillo et al., 2006; Christ et al., 2012), and disrupted fibroblast 
growth factor 8 and noggin expression (Christ et al., 2012).  These data indicate that LRP2 
regulates the patched-1-dependent internalisation and trafficking of sonic hedgehog (Christ 
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et al., 2012), which is necessary for neural stem cell specification and ventral forebrain 
patterning. 
Later in development, the expression of LRP2 by spinal cord radial glial is also necessary for 
glial cell specification.  Lrp2 knockout mice completely lack OL lineage cells, and produce very 
few astrocytes in the spinal cord (Wicher and Aldskogius, 2008).  OPC specification from radial 
glia in the ventral spinal cord is also directed by sonic hedgehog signalling (Poncet et al., 1996; 
Pringle et al., 1996; Orentas et al., 1999; Nery et al., 2001; Tekki-Kessaris et al., 2001), and so 
the lack of spinal cord OLs may be explained by a mechanism similar to that detailed above.  
However OPCs can be generated from cultured neuroepithelial precursors derived from sonic 
hedgehog and smoothened knockout mice (Chandran, 2003; Cai et al., 2005), indicating that 
LRP2 must also interact with other signalling pathways such as basic fibroblast growth factor 
and insulin-like growth factor I (Bolos et al., 2010), to promote OPC generation from neural 
stem cells.  The decreased number of astrocytes observed in Lrp2 knockout mice is also 
interesting.  LRP2 is expressed by vimentin-positive cells in the E15 ventral spinal cord (Wicher 
et al., 2005), that most likely correspond to immature astrocytes (Pringle, 2003; Wu et al., 
2003; Young et al., 2010).  While LRP2 may play a role in regulating the behaviour of astrocytic 
precursors, it is more likely that the observed phenotype is the result of LRP2 being required 
for astrocyte specification by radial glia, as this immature glial population is not generated in 
Lrp2 knockout mice.  Despite these observations that strongly implicate LRP2 in glial cell 
specification during neural development, the ligands and signalling mechanisms are unknown.     
LRP1 appears to fulfil a similar role in regulating glial generation in the brain.  LRP1 is expressed 
by cells within the embryonic ventricular zone, and the early postnatal subventricular zone 
(Hennen et al., 2013).  While the role of LRP1 in regulating neural stem cell function in vivo is 
poorly understood, in vitro studies suggest that LRP1 can regulate OPC production.  Neural 
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stem cells can be harvested from the cortex of embryonic mice, and grown as a suspension 
culture termed neurospheres.  When differentiated, neurospheres generate neurons, 
astrocytes and OLs.  However, neurospheres lacking Lrp1 generate normal numbers of 
neurons, but significantly fewer O4-positive OLs (Hennen et al., 2013).  These data may reflect 
a requirement of LRP1 signalling in neural stem cells for OPC specification, but could equally 
result if LRP1 is necessary for the proliferation or differentiation of OPCs (see OPC section 
below).   
1.15.3 LRPs as Regulators of Neural Stem Cell Proliferation 
 
In the subventricular zone of the adult mouse brain, LRP2 is expressed by ependymal cells 
underlying the neurogenic niche (Zheng et al., 1994; Gajera et al., 2010).  The importance of 
LRP2 expression for neural stem and progenitor cell proliferation was examined in Lrp2267/267 
mutant mice, which produce a truncated form of LRP2 (Zarbalis et al., 2004).  Lrp2267/267 mice 
have ~25% fewer proliferating cells in the subventricular zone relative to control mice, and a 
proportional reduction in the number of newborn neurons entering the olfactory bulb (Gajera 
et al., 2010).  The absence of functional LRP2 from the neurogenic niche was accompanied by 
increased bone morphogenic protein 2 and 4, increased phosphorylation of the downstream 
effectors SMAD1, 5 and 8, and increased activation of the downstream target, Inhibitor of 
DNA binding 3 (Gajera et al., 2010).  It is known that LRP2 can act as an endocytic receptor, 
sequestering and clearing bone morphogenic protein 4 (Spoelgen, 2005).  However this does 
not appear to be the mechanism at play here, as the ventricular infusion of noggin, a potent 
bone morphogenic protein 4 antagonist (Lim et al., 2000), severely decreased neurogenesis, 
but did so in favour of oligodendrogenesis (Sabo et al., 2009), which was not the phenotype 
observed in the Lrp2267/267 mice (Gajera et al., 2010). 
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The ability of LRPs to regulate proliferation may be more widespread amongst immature 
neural cell populations, as LRP1 also regulates the proliferation of cerebellar granular neuron 
precursors.  Cerebellar granular neuron precursors are a temporary cell population that 
proliferate in the external germinal zone of the developing cerebellum, producing granule 
neurons from birth until ~P15 in the mouse (Marzban et al., 2014).  This cell population is 
highly responsive to the pro-mitotic effects of sonic hedgehog (Dahmane and Ruiz i Altaba, 
1999; Wechsler-Reya and Scott, 1999; Haldipur et al., 2012).  However, the effect of sonic 
hedgehog is negatively regulated by an interaction between LRP1 and protease nexin 1, also 
known as SERPINE2.  Protease nexin 1 complexes with its target proteases and binds to LRP1 
on the surface of cultured cerebellar granule neuron precursors (Vaillant et al., 2007).  Once 
endocytosed, protease nexin 1 antagonizes sonic hedgehog signalling, reducing the 
proliferation of cerebellar granule neurons.  This regulation is critical for normal cerebellar 
development, as the absence of protease nexin 1 in vivo delays cerebellar granule neuron 
precursor differentiation, and increases the overall size of the cerebellum (Vaillant et al., 
2007).  We would predict that conditionally removing Lrp1 from cerebellar granule neuron 
precursors would have the same effect. 
1.15.4 LRPs as Regulators of Neuroblast Function 
 
Neuroblast generation and their subsequent migration into the developing cortex has been 
well characterised (Stiles and Jernigan, 2010).  Post-mitotic neuroblasts that are generated in 
the cortical ventricular zone, are destined to form cortical projection neurons (Parnavelas, 
2000).  They undergo radial migration out of the germinal zone, moving along the radial glial 
apical process.  The final laminar position of a newborn neuron is determined by its birth date, 
with late-born neuroblasts migrating past early-born neurons, to seed progressively more 
superficial layers of the cortex (Kriegstein et al., 2006).  In contrast, cortical interneurons are 
generated from radial glial cells within the ventricular zones of the medial ganglionic 
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eminence, the caudal ganglionic eminence, and the pre-optic area, and undergo both radial 
and tangential migration to populate each of the cortical layers (Lavdas et al., 1999; Letinic et 
al., 2002; Nery et al., 2002).   
Neuroblasts born in the two neurogenic niches of the adult brain also have vastly different 
migratory requirements.  Those born in the hippocampus are destined to be dentate granule 
neurons, which project from the dentate gyrus to CA3 of the hippocampus (Hastings and 
Gould, 1999).  After birth these cells move a very short distance as they mature – migrating 
from the subgranular zone (the inner lip) of the dentate granule neuron layer, to their final 
position within the layer.  On the other hand, neuroblasts born in the subventricular zone 
migrate tangentially, moving as neuroblast chains through the rostral migratory stream into 
the olfactory bulb (Doetsch et al., 1999).  Upon exiting the rostral migratory stream, the 
neuroblasts turn and migrate radially and differentiate into granule and periglomerular 
neurons in the olfactory bulb (O'Rourke et al., 2014).  This type of chain migration is regulated 
by signals that modify the actin cytoskeleton, contact-mediated signalling between the 
neuroblasts and the ensheathing glia (Tomasiewicz et al., 1993; Hu et al., 1996; Chazal et al., 
2000; Alberti et al., 2005) as well as chemorepulsion mediated by slit and netrin (Wu et al., 
1999; Murase and Horwitz, 2002; Nguyen-Ba-Charvet, 2004).   Recent evidence suggests, that 
following neural stem cell specification and neuroblast generation, LDL family members, 
including LRP1 and LRP2, continue to play a significant role in regulating the successful 
maturation and integration of these new cells in the CNS. 
1.15.5 LRP8 and the VLDL Receptor are Key Regulators of Neuroblast Migration in 
Development and Adulthood 
 
 Lrp8 and VLDL receptor double knockout mice have abnormalities in the layering of the brain, 
including the ectopic placement of neurons (Trommsdorff et al., 1999; Weeber et al., 2002), 
and also exhibit malformation of the cerebellum and spinal cord (Trommsdorff et al., 1999; 
 23 
Su et al., 2013).  LRP8 and the VLDL receptor are high affinity receptors for reelin (D'Arcangelo 
et al., 1997; Hiesberger et al., 1999) a large extracellular matrix protein (D'Arcangelo et al., 
1997; Trommsdorff et al., 1999; Su et al., 2013).  Fittingly, mice lacking reelin largely 
phenocopy the very distinct and unique cortical lamination defects seen in the Lrp8 and VLDL 
receptor double knockout mice (D'Arcangelo et al., 1997; Trommsdorff et al., 1999; Su et al., 
2013).  Oligomeric reelin binds to LRP8 and the VLDL receptor, activates Src family kinases, 
and induces phosphorylation of disabled-1.  This signalling pathway enables polarisation, 
adhesion, stabilisation, process outgrowth, and ultimately neuroblast migration (Nichols and 
Olson, 2010; Sekine et al., 2012).  During development reelin is first expressed in the cortical 
marginal zone by Cajal-Retzius cells (Frotscher, 1998; Marín-Padilla, 1998; Soriano and del 
Río, 2005), and later by interneurons (Alcántara et al., 1998; Drakew et al., 1998).  Humans 
with mutations of the VLDL receptor gene are at increased risk of schizophrenia, which is 
thought to be due to subtle neuroblast migration defects within the brain (Deutsch et al., 
2010).   
LRP8 and the VLDL receptor can also regulate neuroblast migration when activated by an 
alternative ligand, thrombospondin-1.  Thrombospondin-1 is expressed in the subventricular 
zone and throughout the rostral migratory stream (Blake et al., 2008), where it acts on LRP8 
and the VLDL receptor to promote neuroblast chain migration.  Thrombospondin-1 knockout 
mice have defective chain migration, with fewer neuroblasts successfully migrating to the 
olfactory bulb (Blake et al., 2008).  This phenotype is also observed in mice lacking LRP8 and 
VLDL receptor, or disabled-1, but is not observed in reelin knockout mice (Andrade et al., 
2007).  However, the successful migration of neurons from the subventricular zone to the 
olfactory bulb appears to require both ligands.  Thrombospondin-1 stabilizes neuroblast 
chains and increases their length in the subventricular zone and rostral migratory stream, but 
reelin, produced by mitral cells in the olfactory bulb, is a higher affinity ligand, and 
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subsequently directs neuroblast dissociation, allowing them to transition to radial migration 
(Hack et al., 2002).  Of the two ligands, only reelin activates the proteasomal degradation of 
disabled-1, which is necessary for neuroblast dissociation (Blake et al., 2008).      
There is no evidence that reelin signalling interacts with LRP1 or LRP2.  However, 
thrombospondins are known to interact with membrane proteins such as integrins, CD47, 
CD36, proteoglycans, and LRP1.  Thrombospondin-1 has been shown to interact with LRP1 in 
combination with calreticulin to promote focal adhesion, and this interaction is an important 
regulator for mature oligodendrocytes (Gudz, 2006) and microglia (Le Marrec-Croq et al., 
2014), but has not been demonstrated to regulate neuroblast migration.  
1.15.6 LRPs, Neuroblast Migration and Neuronal Development 
 
LRP2 regulates neuroblast migration indirectly.  In vitro LRP2 and caveolins are expressed by 
astrocytes, and have been demonstrated to bind and endocytose albumin (Bento-Abreu et 
al., 2008; 2009).  This is significant, as albumin uptake activates the transcription factor sterol 
regulatory binding element protein 1, inducing expression of stearoyl-coA 9-desaturase-1, 
the key enzyme required for synthesis of the neurotrophic factor oleic acid (Tabernero et al., 
2002).  In the lateral periventricular zone of the developing rat brain, oleic acid production 
regulates neuronal growth, migration, axon generation, and early synaptogenesis (Polo-
Hernández et al., 2010; 2014), with the major neurotrophic effect being mediated by PPAR-
α, protein kinase A and neuro D2 (Granda et al., 2003).  When stearoyl-coA 9-desaturase-1 is 
knocked down in lateral periventricular explant cultures, albumin-mediated neuroblast 
migration is essentially prevented (Polo-Hernández et al., 2014).   
Once neuroblasts stop migrating, their journey is far from over.  The immature neurons 
extend an axonal process to commence formation of the circuitry of the nervous system.  The 
extending axons are tipped with a growth cone, which navigates the extracellular matrix, 
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guiding the axon to its target cell to ultimately form a synapse (Caudy and Bentley, 1986).  A 
growth cone comprises a membranous, receptor-rich, fan-shaped lamellipodia that extends 
along finger-like projections known as filopodia.  The growth cone cytoskeleton is comprised 
of closely interacting microtubules, and filamentous- and globular-actin (Lewis and Bridgman, 
1992; Bentley and O'Connor, 1994; Suter and Forscher, 2000).  Bundles of filamentous actin 
give structure to the filopodia, as does the cross-linked filamentous actin along the 
lamellipodial leading edge (Lewis and Bridgman, 1992; Korey and Van Vactor, 2000; Suter and 
Forscher, 2000).  Microtubules are arranged as parallel bundles along the axon and splay 
outwards within the growth cone, providing structure and transport for proteins and 
organelles (Dailey and Bridgman, 1989).   
Growth cones are fitted with an elaborate suite of receptors that allow for the simultaneous 
integration of a multitude of chemotactic cues (Tessier-Lavigne and Goodman, 1996).  Binding 
of a chemotactic factor to its specific receptor/s on the growth cone membrane, induces an 
intracellular signalling cascade which manipulates the cytoskeletal elements, and dictates 
whether the response of the growth cone culminates in turning, extension, stasis, retraction, 
collapse or bifurcation (Suter and Forscher, 2000).  Well defined receptors for chemotactic 
signals include the Eph family of receptor tyrosine kinases, Neuropilin, Roundabout, Deleted 
in Colorectal Cancer, L1 and Plexins (reviewed in (Dickson, 2002)).   
LRP1 and LRP2 are highly expressed on the growth cones of developing neurons in vitro, and 
have been shown to signal in a co-dependent manner to promote chemotactic axon guidance 
within developmental neurons in vitro (Landowski et al., 2016).  Together, LRP1 and LRP2 act 
as chemotactic receptors for a variety of ligands, including metallothioneins and tissue-type 
plasminogen activator (Landowski et al., 2016).  Metallothioneins are small, highly conserved, 
inducible heavy metal binding proteins that are avid scavengers of reactive oxygen species 
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(Thornalley and Vasák, 1985).  Metallothioneins I and II are widely expressed in the nervous 
system and elsewhere.  They differ by only a few amino acids and appear to have redundant 
functions.  Metallothionein III is highly expressed in the brain, while metallothionein IV 
appears to be absent from the nervous system (Hidalgo et al., 2001).  In cultured growth 
cones from sensory neurons, the activation of LRP1 and LRP2 by metallothionein II stimulated 
chemo-attraction, resulting in growth cones turning towards the source of metallothionein II 
(Landowski et al., 2016).  Metallothionein III had the opposite effect and induced chemo-
repulsion.  Other LRP1 ligands, such as α2-macroglobulin, and tissue-type plasminogen 
activator also induced chemorepulsion (Landowski et al., 2016).   
The opposing responses induced by different LRP1 ligands are thought to result from 
differential activation of downstream signaling pathways, with metallothionein II activating 
Ca2+ / calmodulin-dependent protein kinase and other receptors such as the tropomyosin-
related kinase A receptor in complex signaling hubs.  
Various LRP ligands have also been shown to alter neurite outgrowth. For example, 
metallothionein I/II signalling has been shown to transiently activate Akt and ERK, which 
belong to the mitogen-activated protein kinase and the phosphoinositide-3 kinase / Akt 
intracellular signalling pathways (Leung et al., 2011).  Myelin associated glycoprotein, an 
established chemorepulsive molecule, is known to interact with LRP1 (Stiles et al., 2013)  and  
is a major constituent of the OL myelin sheath, which inhibits axonal outgrowth, and induces 
growth cone collapse (Henley et al., 2004; Hines et al., 2010).  In vitro experiments have 
demonstrated that myelin associated glycoprotein and LRP1 form a complex with the p75 
neurotrophin receptor, to activate RhoA (Stiles et al., 2013), a potent mediator of growth 
cone collapse and axon retraction (Wu et al., 2005).  Additionally apolipoprotein E-containing 
lipoproteins are secreted by astrocytes and have been shown to bind LRP1 on the surface of 
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immature neurons to promote neurite outgrowth generally, without having an effect on 
directionality (Nakato et al., 2015). The complexity of LRP signalling interactions in immature 
neurons remains to be fully deciphered but appear to be context- and ligand- dependant 
(Mantuano et al., 2013a) 
Mice in which Lrp1 is selectively deleted from neurons, exhibit prominent tremor and 
dystonia, behavioural abnormalities, hyperactivity, motor dysfunction, age-dependent 
dendritic spine degeneration, synapse loss, neuroinflammation, memory loss, eventual 
neurodegeneration, and premature death (May et al., 2004; Mulder et al., 2004; Liu et al., 
2010), clearly demonstrating that LRP1 is crucial to neuronal function.   LRP1 is also found 
postsynaptically, where it can interact with NMDA receptors in vitro, via the intracellular 
scaffold postsynaptic density protein 95 (Gotthardt et al., 2000; May et al., 2004).  LRP1 is 
able to influence the activity of NMDA receptors and regulate their distribution and 
internalisation (Maier et al., 2013; Nakajima et al., 2013; Mantuano et al., 2013a), as well as 
the NMDA-induced internalisation of the AMPA receptor subunit GluR1 (Nakajima et al., 
2013).  The very nature of this LRP1 / NMDA receptor relationship suggests LRP1 plays an 
integral role in neurotransmitter-induced calcium signalling, particularly in synaptic plasticity 
(Maier et al., 2013; Nakajima et al., 2013).   
Another LRP family member, LRP8, has been shown to regulate synaptic plasticity (Weeber 
et al., 2002; Qui et al., 2006).  More recently, LRP8 activation by the addition of reelin to 
primary mouse cortical neurons, was shown to trigger the proteolytic cleavage of LRP8 by γ-
secretase.  This liberated the intracellular domain, which translocated to the nucleus, and 
along with phosphorylated CREB, enhanced the transcription of genes associated with 
learning and memory (Telese et al., 2015).  The ability of neurons to acquire energy for 
demanding tasks, may also be indirectly tied to a role of LRP1 in regulating glucose uptake.  
 28 
Cultured neurons lacking Lrp1 exhibit reduced expression of the glutamate transporters 
GLUT3 and GLUT4 (Liu et al., 2015).   
1.16 LRP1 and LRP2 as Regulators of Oligodendrocyte Progenitor Cell Function 
 
In the mouse spinal cord, OPC generation commences from the ventral pMN domain at E12.5 
(Noll and Miller, 1993; Richardson et al., 2006).  The pMN domain is named for its role in 
generating spinal cord motor neurons, and is defined by the expression of two transcription 
factors, OLIG1 and OLIG2 (Zhou et al., 2000), both of which are highly expressed by OPCs and 
necessary for their generation and subsequent differentiation (Lu et al., 2000; Dai et al., 2015).  
Olig1/2 expression by pMN domain neural stem cells is induced by a gradient of ventrally 
secreted sonic hedgehog, suggesting that specification of this domain would also be LRP1/2-
dependant.  In the absence of Olig1/2, stem cells in the pMN domain instead form V2 
interneurons and astrocytes (Zhou and Anderson, 2002).  Shortly after their birth, OPCs 
differentiate into myelinating OLs in the spinal cord grey and white matter (Pringle and 
Richardson, 1993; Fok-Seang and Miller, 1994).  It is estimated that approximately 85% of all 
spinal cord oligodendrocytes originate from the pMN domain, but other domains such as the 
P3 domain (Richardson et al., 2006), and more dorsal domains (Fogarty, 2005; Tripathi et al., 
2011) also produce OPCs, just slightly later in response to different spatio-temporal cues.  
1.17 LRP2 regulates OPC Proliferation and Migration during Development 
 
One of the signalling molecules regulating OPC proliferation and migration is sonic hedgehog 
(Murray et al., 2002; Gao and Miller, 2006), and LRP2 appears to regulate OPC proliferation 
and migration by modulating sonic hedgehog availability, and contributing to the generation 
of a concentration gradient.  In the developing mouse optic nerve, LRP2 is highly expressed by 
astrocytes (Ortega et al., 2012).  However, LRP2 expression is not homogeneous, being highest 
in the caudal optic nerve at E14.5, but then changing to be highest in the rostral optic nerve 
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at E16.5.  Blocking LRP2 signalling by optic nerve astrocytes leads to a significant reduction in 
OPC proliferation and migration (Ortega et al., 2012).  In vitro studies suggest that the LRP2-
mediated up-take and release of sonic hedgehog by astrocytes, promotes OPC proliferation 
and acts as a chemo-attractant directing their migration (Ortega et al., 2012).  The temporal 
regulation of LRP2 expression in the caudal versus rostral regions of the optic nerve, would be 
predicted to ‘trap’ sonic hedgehog in the region being populated by OPCs at that time.  The 
expression pattern of LRP2 in the postnatal optic nerve has not been characterised.  However 
as LRP2 is expressed by mature oligodendrocytes in the postnatal spinal cord (Wicher et al., 
2006), it might also be up-regulated by optic nerve OPCs upon differentiation.           
1.18 How Might LRP1 Influence OPC Behaviour?  
 
1.18.1 OPC migration 
 
When examining LRP1 function in other cell types, there are a number of mechanisms by 
which LRP1 could feasibly influence OPC behaviour.  For example OPC processes share some 
structural similarities with the growth cones of developing neurons (Schmidt et al., 1997; 
Simpson and Armstrong, 1999).  In particular growth cones comprise specialised cell 
membrane extensions called lamellipodia and filopodia, which also extend from the cellular 
processes of OPCs (Schmidt et al., 1997).  LRP1 signalling mediates chemo-attraction and 
chemo-repulsion of growth cones in vitro (Landowski et al., 2016), so perhaps LRP1 could 
regulate OPC process guidance, or even OPC migration.  LRP1 is expressed by Schwann cells 
in vivo, and regulates the migration and adhesion of immature Schwann cells in vitro, by the 
activation and repression of two small Rho GTPases, Rac1 and RhoA respectively (Mantuano 
et al., 2010).  Rac1 activation stimulates the formation of peripheral lamellae by actin 
remodelling in the leading process (Pankov et al., 2005).  Lrp1 knockdown decreases Rac1 
activation, and increases RhoA activation, which in turn increases cell adhesion and prevents 
migration (Mantuano et al., 2010).  This is of particular interest, as OPCs take on a bipolar 
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morphology when migrating (Simpson and Armstrong, 1999), and their movement has been 
attributed to the NG2-dependent regulation of small Rho GTPases and polarity complex 
proteins (Biname et al., 2013).   
LRP1 also has the potential to influence OPC migration by acting as a co-receptor for PDGFRα 
signalling, in a similar way that it promotes fibroblast migration by co-signalling with PDGFRβ.  
When PDGF-BB binds to PDGFRβ on the surface of cultured mouse embryonic fibroblasts, it 
induces migration.  However this involves the association of LRP1 with PDGFRβ (Muratoglu et 
al., 2010; Craig et al., 2013).  The two receptors are internalized and co-localize in the 
endosomal compartment, where the kinase domain of PDGFRβ phosphorylates the distal 
NPxY motif of LRP1 (Loukinova, 2002; Newton et al., 2005; Muratoglu et al., 2010).  Once 
phosphorylated, LRP1 has an increased affinity for the intracellular domain for SHP-2 
(Rönnstrand et al., 1999; Craig et al., 2013), out competing PDGFRβ for this interaction, and 
preventing further activation of downstream signalling pathways (Craig et al., 2013).  While 
OPCs do not express PDGFRβ, they express high levels of the related receptor, PDGFRα, which 
is also internalised following ligand binding (Avrov and Kazlauskas, 2003), suggesting an 
association with an unidentified endocytic receptor – which we propose could be LRP1.  PDGF-
AA is known to binds to PDGFRα on the surface of OPCs, and activate a phosphorylation 
cascade involving the Fyn tyrosine kinase and cyclin-dependant kinase 5 (Miyamoto et al., 
2008), a known regulator of the actin cytoskeleton in neurons (Chae et al., 1997).  By 
interacting with PDGFRα it is feasible that LRP1 could promote not only OPC migration, but 
also proliferation and cell survival (Richardson et al., 1988; Rosenkranz et al., 1999; McKinnon, 
2005; Miyamoto et al., 2008).  While the signalling mechanism is likely to be different, a role 
for LRP1 in regulating cell survival is not unprecedented, as LRP1 has been shown to protect 
Schwann cells against TNFα-induced cell death in a sciatic nerve crush injury model in vivo and 
in vitro (Campana et al., 2006). 
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LRP1 could be necessary for OPC migration by instead regulating lipid availability within the 
cell, as the establishment of cell polarity and movement of the leading edge during migration 
is dependent on the availability of cholesterol (Mañes et al., 1999; Mañes and Martıńez-A, 
2004).  Most lipid-carrying proteins cannot cross the blood brain barrier, and therefore must 
be generated within the CNS.  Apolipoprotein E is secreted by astrocytes, and functions as an 
effective lipid transport protein, and can bind LRP1 (Boyles et al., 1985; Beisiegel et al., 1989).  
Lipoproteins form non-covalent aggregates with triglycerides, phospholipids and cholesterol 
esters before they bind to specific receptors where they can be internalised and utilized by 
the cell (Morrisett et al., 1975).  Upon binding of apolipoprotein E to LRP1, the complex is 
internalised where its lipid content is discharged, making it available to the cell (Willnow et 
al., 2007), before Apolipoprotein E is re-secreted (Laatsch et al., 2012).  Once internalized, 
lipoproteins maybe utilized by OPCs for a number of functions.  Forebrain neuron-specific Lrp1 
gene knockout mice have severe deficiencies in lipid metabolism, and show significant 
synapse loss (Liu et al., 2010), and LRP1-mediated lipid uptake may alternatively allow OPCs 
to sustain their post-synaptic connections with neurons.  The presynaptic use of cholesterol 
by neurons is high, due to the requirements of lipid-rich neurotransmitter vesicles (Pfrieger, 
2003).  However, the postsynaptic cell also utilizes cholesterol for receptor recycling in and 
out of the post-synaptic membrane.  Therefore, cholesterol uptake into OPCs may be critical 
for formation of the axon-OPC synapse, and maintenance of the OPC post-synaptic density.  
1.18.2 Inflammatory response  
 
Microglia are the resident immune cell of the CNS and become activated in response to injury, 
infection or in neurodegenerative disease;  and express high levels of LRP1 (Marzolo et al., 
2000; Auderset et al., 2016a). Microglial specific deletion of LRP1 has been shown to worsen 
disease severity in EAE as microglia adopt a pro-inflammatory phenotype and increase 
production of tissue necrosis factor alpha (TNF-a) (Chuang et al., 2016), which suggests that 
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normally, microglial LRP1 is required to maintain these cells in an anti-inflammatory and 
neuroprotective state following injury. Furthermore, knockdown of LRP1 in primary murine 
microglia led to enhanced sensitivity to LPS as a result of activation in NF-kb and c-Jun N-
terminal kinase (JNK) signalling pathways which again, led to the conclusion that LRP1 is 
required to maintain microglia in a non-activated state (Yang et al., 2016). Brifault et al found 
that by adding RAP to mouse microglial cultures they were able to induce LRP1 shedding from 
the membrane which led to the adoption of a more inflammatory phenotype and increased 
microglial proliferation and migration.  When RAP and sLRP1 was injected directly into the 
dorsal horn of mouse spinal cords, significantly more microglia were observed at the injection 
site as well as increased expression of proinflammatory mediators such as TNF-a and IL-6 
(Brifault et al., 2017).   
 
 
1.19 LRP1 as a Regulator of Adult OPC Behaviour  
A number of signalling pathways have been identified that are involved in regulating 
developmental and adult OPC behaviour, or oligodendrogenesis, including Notch1 (Genoud 
et al., 2002; Givogri et al., 2002; Zhang et al., 2009), FGF2 (Murtie et al., 2005; Zhou et al., 
2006; Murcia-Belmonte et al., 2014), mTOR (Zou et al., 2014; Jiang et al., 2016; Grier et al., 
2017) and PDGF (McKinnon, 2005; Rajasekharan, 2008; Chew et al., 2010) , however the full 
extent of ligand-receptor and downstream cell signalling interactions regulating OPC function 
is far from being fully understood. Within the OL lineage, LRP1 is exclusively expressed by 
OPCs, and downregulated with differentiation (Auderset et al., 2016a).  LRP1 can signal in a 
variety of ways including ligand endocytosis (Cam et al., 2005; Parkyn et al., 2008; Liu et al., 
2017; Van Gool et al., 2019), receptor trafficking (Parkyn et al., 2008; Maier et al., 2013; 
Kadurin et al., 2017) and cleavage and formation of a soluble product (May, 2002b; Liu et al., 
 33 
2009; Brifault et al., 2017; 2019).  Previous studies have found that deleting LRP1 can also 
directly regulate the function of cells of the oligodendrocyte lineage, as the conditional 
deletion of Lrp1 from OLIG2+ cells using Olig2-Cre :: Lrp1fl/fl mice impaired oligodendrogenesis 
and myelination in the developing mouse optic nerve (Lin et al., 2017).  As OPC physiology 
changes considerably between development and adulthood (Velez-Fort et al., 2010), and OPC 
behaviour can differ between CNS regions (Spitzer et al., 2019), we employed a conditional 
gene deletion approach to determine how LRP1 influences adult OPC behaviour and 
oligodendrogenesis in the adult mouse brain.  The aim of this study was to determine how 
























Chapter 2: Methods  
2.1 Animal housing and mice 
All animal experiments were approved by the University of Tasmania Animal Ethics 
(A0016151) and Institutional Biosafety Committees and were carried out in accordance with 
the Australian code of practice for the care and use of animals for scientific purposes.  Pdgfra-
CreERT2 mice (Rivers et al., 2008) were a kind gift from Prof William D Richardson (University 
College London).  Pdgfra-CreERTM  (Kang et al., 2010a), Pdgfra-H2BGFP [(Pdgfra-histGFP  
(Hamilton et al., 2003); Jackson stock # 007669)] and Lrp1fl/fl (Herz et al., 1992) mice were 
purchased from Jackson Laboratories.  Cre-sensitive Rosa26-YFP (Srinivas et al., 2001) and 
Tau-mGFP (Hippenmeyer et al., 2005) reporter mice were also purchased from Jackson 
laboratories.  Mice were maintained on a C57BL/6 background and inter-crossed to generate 
offspring for experimental use.  All mice were weaned >P30 to ensure appropriate myelin 
development; were group housed with same-sex littermates in Optimice micro-isolator cages 
(Animal Care Systems, Colorado, USA), and were maintained on a 12-hour light / dark cycle at 
20°C, with uninhibited access to food and water.   
Please note that two distinct Pdgfrα-CreER transgenic mouse lines used in this study: the 
Pdgfrα-CreERTM transgenic mouse line, generated by Kang et al. (2010b), was used for the 
majority of experiments, and the lower efficiency (LE) Pdgfrα- CreERT2 transgenic mouse line, 
generated by Rivers et al. (2008), was used to perform the Tau-mGFP lineage tracing 
experiments, as we have previously demonstrated that Pdgfrα-CreERTM transgenic mouse  are 
not compatible with the Tau-mGFP reporter [see (Pitman et al., 2019)].    
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2.2 DNA extraction and amplification  
Ear biopsies were digested overnight in DNA extraction buffer (100mM Tris-HCl, 5mM EDTA, 
200mM NaCl, 0.2% SDS and 120ng of proteinase k) at 55°C.  Genomic DNA was then extracted 
by first precipitating cellular and histone proteins by cold incubation in 6M Ammonium 
Acetate (Sigma; A1542), followed by precipitation of the DNA in room temperature isopropyl 
alcohol (Sigma; I9516).  The DNA pellet was washed in 70% Ethanol (Sigma; E7023), 
resuspended in sterile MilliQ water and used as template DNA to genotype the mice by 
polymerase chain reaction (PCR).  The PCR was performed as a 25µL reaction containing: 50-
100ng DNA; 0.5µL of each primer (100nmol/mL, GeneWorks); 12.5 µL GoTaq® green master 
mix (Promega) and MilliQ water.  The following primers were used: Lrp1 5’ CATAC CCTCT 
CAAACC CCTT CCTG and Lrp1 3’ GCAAG CTCC CTGCTCA GACC TGGA ; Cre 5’ CAGGT CTCAG 
GAGCT ATGTC CAATT TACTG ACCGTA and Cre 3’ GGTGT TATAAG CAATCC CCAGAA, or GFP 5’ 
CCCTG AAGTTC ATCTG CACCAC and GFP 3’ TTCTC GTTGG GGTCT TTGCTC in a program of: 94°C 
for 4’, and 34 cycles of 94°C for 30”, 60°C for 45”, and 72°C for 60”, followed by 72°C for 10 
minutes.  To genotype mice expressing the Rosa26-YFP transgene we used three primers: 
Rosa26 wildtype 5’ AAAGT CGCTC TGAGT TGTTAT, Rosa26 wildtype 3’ GGAGC GGGAG AAATG 
GATATG and Rosa26 mutant 5’ GCGAA GAGTT TGTCC TCAACC in a program of: 94°C for 4’, and 
37 cycles of 94°C for 30”, 62°C for 45”, and 72°C for 1’, followed by 72°C for 10’.  The DNA was 
then separated by gel electrophoresis (2% w/v agarose in TAE containing SYBR-safe, 
ThermoFisher), and imaged using an Image Station 4000M PRO gel system running 
Carestream software.  
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2.3 Tamoxifen preparation and administration  
Tamoxifen (Sigma,T5648) was dissolved by sonication in corn oil (Sigma) at a concentration of 
40mg/ml for 2 hours at 21°C.  Adult mice were administered tamoxifen (300mg/kg) via oral 
gavage daily for 4 consecutive days. Mice were weighed and monitored daily. No side-effects 
of tamoxifen administration were observed. Our dosing regimen provides the maximal 
amount of tamoxifen that can be tolerated by young adult mice without observing adverse 
side-effects (Rivers et al., 2008).  
2.4 EdU administration and labelling 
For in vivo labelling, 5-Ethynly-2’-deoxyuridine (EdU; Thermofisher, E10415,) was 
administered to mice via their drinking water at a concentration of 0.2mg/ml for up to 21 
consecutive days (as per Clarke et al., 2010).  For in vitro labelling, EdU was added to complete 
OPC medium at a final concentration of 2.5µg/ml in complete OPC medium for 10 hours 
before the cells were fixed with 4% (w/v) paraformaldehyde in PBS for 15 minutes at room 
temperature. EdU developing cocktail was made instructions outlined in the AlexaFluor-647 
Click-IT EdU kit (Invitrogen, C10340) with brain slices being exposed to the developing reagent  
for 45 minutes and coverslips being exposed for 15 minutes.  
2.5 Generation of mixed glial cultures and purification and differentiation of OPCs  
The cortices of P1-10 mice were dissected into EBSS (Invitrogen, 14155-063), diced into pieces 
~1mm3 and digested in 2ml of EBSS containing trypsin (final conc 0.06mg/ml, Sigma,T4799) at 
37°C for 10 minutes.  The trypsin was inactivated by the addition of foetal bovine serum (FBS) 
then rinsed twice in EBSS and triturated in EBSS with DNAseI (final concentration 0.12mg/ml, 
Sigma, 5025) and filtered through a 40µm sieve (Corning, 352340).  After centrifugation at 
300rcf for 5 minutes, the cells were resuspended in complete OPC medium (20ng/ml human 
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PDGF-AA (Peprotech), 10ng/ml bFGF (R&D Systems), 10ng/ml human CNTF (Peprotech), 
5µg/ml NAC (Sigma), 1ng/ml NT3 (Peprotech), 1ng/ml Biotin (Sigma), 10µM Forskolin (Sigma), 
1X Pen/Strep (Invitrogen), 2% B27 (Invitrogen), 50µg/ml Insulin (Sigma), 600ng/ml 
Progesterone (Sigma) 1mg/ml Transferrin (Sigma), 1mg/ml BSA (Sigma), 400ng/ml Sodium 
Selenite (Sigma) 160µg/ml Putrescine (Sigma) in DMEM+ Glutamax (Invitrogen, 10569069) 
and plated on 6 well plates coated with >30,000 MW Poly D-Lysine (PDL; Sigma, P7405).   
2.5.1 Purifying OPCs by immunopanning  
 
After 7 DIV, OPCs were purified using a modified version of the Emery and Dugas (2013) 
immunopanning protocol.  Cells were dislodged by incubating in 1:5 TrypLE (Gibco, 12604013) 
in EBSS for ~10 minutes. The TrypLE was then inactivated by adding FBS then the cells were 
washed in EBSS prior to being collected and centrifuged for 5 minutes at 300rcf. OPCs were 
then immunopanned (Emery and Dugas, 2013).  
2.5.2 Differentiation of purified OPCs 
 
 
To differentiate OPCs, the complete OPC medium was removed and replaced with OPC 
differentiation medium [complete OPC medium lacking PDGF-AA and containing 4µg/ml 
triiodothyronine (Sigma)].   
2.6 Gene deletion in vitro 
Following immunopanning, purified OPCs plated at a density of 20,000 cells per 13mm 
coverslip were allowed to settle for two days.  TAT-Cre (Excelgen, EG1001) was then added to 
complete OPC medium at a final concentration of 1µM for 90 minutes at 37°C and 5% CO2.  
The medium containing TAT-Cre was then removed and replaced with fresh complete OPC 
medium and returned to the incubator for 48 hours.   
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2.7 Western blot 
2.7.1 Generation of lysates 
 
Mouse brain lysates were produced by lysing tissue in RIPA cell lysis buffer (50mM Tris-HCL, 
150mM NaCl , 1%NP-40, 1% Sodium Deoxycholate , 0.1% SDS and one phosphatase inhibitor 
tablet).  Samples were centrifuged for 1 minute at 10,000 rpm in a bench-top centrifuge and 
the supernatant was collected and stored at -80°C.  
2.7.2 Protein quantification 
 
The amount of protein in each sample was quantified by performing a Bradford protein 
quantification assay.  Six bovine serum albumin (BSA) standards (ranging from 0-2mg/mL) 
were prepared by diluting the 2mg/mL BSA standard (Sigma) in MilliQ water.  Each brain lysate 
was diluted 1:10 in MilliQ water, and 5μL of each sample or standard was plated in triplicate.  
Twenty five microlitres of the Bio-Rad DCTM Protein Assay Reagent (Biorad; comprising1ml of 
Reagent A and 20μL of Reagent S) and 200µL of DCTM Protein Assay Reagent B was added to 
each well and the plate was placed on an orbital shaker for 15 minutes before being analysed 
using the FLUOstar OPTIMA microplate reader (BMG Labtech, Baden-Württemberg, 
Germany).  Standard absorbance readings, presented as optical density, were used to 
calculate the protein concentration for each lysate.   
 
2.7.3 Protein gel electrophoresis  
 
Ten micrograms of protein lysate was combined with 10μl of 4x Bolt LDS sample buffer and 
4μl of reducing agent (500mM Dithiothreitol) and made up to 40μl with MilliQ water, before 
each sample was incubated at 70°C for 10 minutes.  Precast polyacrylamide 4%-12% Bolt Bis-
Tris Plus Gels (Life Technologies) were prepared according to the manufacturer’s instructions.  
10µL of Seablue Plus2® (Life Technologies) protein ladder was added to the first well and 40μL 
of lysate to the remainder.  The gel was run at 140 volts for 45 minutes at 21°C, before being 
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removed from it casing and left to equilibrate in 1x transfer buffer (5% Bolt Transfer buffer / 
10% Ethanol / MilliQ water) for 10 minutes.  The gel sandwich was constructed according to 
the manufacturer’s instructions and the protein was transferred onto an ethanol-activated 
PVDF membrane (Biorad) for 60 minutes at 20 volts and 4°C.  The membrane was transferred 
into blocking solution [5% (w/v) skim milk powder, 0.05% (v/v) tween-20 in tris buffered saline 
(TBS)] and incubated on the orbital shaker for 60 minutes at 21°C, before being transferred 
into blocking solution containing rabbit anti-LRP1 (1:40000, ab92544, Abcam) and mouse anti-
GAPDH (1:40000, AB2302, Millipore).  The membrane was incubated on the orbital shaker 
overnight at 4°C, before being washed 5 x 15 minutes in TBS /0.2% tween-20 at 21°C while 
agitating.  The relevant horseradish peroxidase (HRP) conjugated secondary antibodies [goat 
anti-mouse HRP (1:20000, P044701-2, Dako) or goat anti-rabbit HRP (1:20000, P044801-2, 
Dako)] were diluted in TBS / 0.2% Tween20 and applied to the membrane for 1 hour on an 
orbital shaker at 21°C.  The membrane was washed as described previously and exposed to 
equal volumes of Immobilon Western™ HRP Peroxidase Solution (Millipore) and Luminol 
Reagent (Millipore) for visualisation of the protein bands on an Image Station 4000M PRO, 
using Carestream software (Rochestern NY14608).  Western blot band intensity was 
calculated by measuring integrated density and normalizing to a loading control.    
 
 
2.8 Whole cell patch clamp electrophysiology 
Adult (P57+30) control and LRP1-deleted mice expressing GFP selectively in OPCs were 
sacrificed by cervical dislocation and their brains dissected into an ice-cold sucrose solution 
containing: 75 mM sucrose, 87 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 7 
mM MgCl2, and 0.95 mM CaCl2.  Coronal vibratome slices (300 μm) were prepared using a 
Leica VT1200s vibratome and incubated at 31.7C in artificial cerebral spinal fluid (ACSF) 
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containing: 119 mM NaCl, 1.6 mM KCl, 1 mM NaH2PO4, 26.2 mM NaHCO3, 1.4 mM MgCl2, 2.4 
mM CaCl2, and 11 mM glucose (300 ± 5 mOsm/kg), saturated with 95% O2/5% CO2. After 45 
min, slices were transferred to ~21°C ASCF.  For recording slices were transferred to a bath 
constantly perfused with ~21°C ACSF (2 mL/min). Recording electrodes were prepared from 
glass capillaries and had a resistance of 3–6 MΩ. For recording currents through voltage gated 
calcium channels electrodes were filled with an internal solution containing 125 mM Cs-
methanesulfonate, 4mM NaCl, 3mM KCl, 1mM MgCl2, 8mM HEPES, 9mM EGTA, 10 mM 
phosphocreatine, 5 mM MgATP, and 1 mM Na2GTP, set to a pH of 7.2 with CsOH and an 
osmolarity of 290 ± 5 mOsm/kg.  For AMPA/kainate receptor currents, an internal solution 
containing 125 mM Cs-methanesulfonate, 5mM TEA-Cl, 2mM MgCl2, 8mM HEPES, 9mM EGTA, 
10 mM phosphocreatine, 5 mM MgATP, and 1 mM Na2GTP set to a pH of 7.2 with CsOH and 
an osmolarity of 290 ± 5 mOsm/kg was used.  
Whole cell patch clamp recordings of GFP+ cells in the motor cortex were collected using a 
HEKA Patch Clamp EPC800 amplifier and pCLAMP 10.5 software (Molecular devices). Upon 
breakthrough cells were held at −50 mV and a series of voltage steps up to +30 mV applied to 
determine the presence of a voltage-gated sodium channel current.  Cells with a voltage-gated 
sodium current greater than 100pA were considered OPCs and used for further analysis.  For 
L-Type and T-Type voltage gated calcium channel recordings the perfusate was subsequently 
switched to a calcium recording solution containing 20 mM BaCl2, 125 mM choline Cl, 5 mM 
tetraethyl ammonium, 10 mM glucose, and 10 mM HEPES, set to a pH of 7.4 with CsOH and 
an osmolarity of 300 ± 5 mOsm/kg. To record T-type currents cells were held at −50 mV and 
the cell was hyperpolarised to -120mV for 200ms before voltage steps from -70mV to 30mV 
were applied. The current density relationship of steady state currents in the last 100ms of 
the voltage steps were reported from an average of 3 recordings per cell.  To record L-type 
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currents, cells were held at −50 mV and a series of 500 ms voltage steps, from −60 to +30 mV, 
was applied using a P/N subtraction protocol and the current density relationship was plotted 
from the average of 3 recordings per cell.  
For recording currents through AMPA/kainate receptors, the perfusate was switched to ACSF 
containing 50µm APV (Sigma) and 1µM TTX (Sigma). After 3 minutes, cells were voltage 
clamped at -60 mV and currents elicited by 200 ms voltage steps from -80 to 20 mV (20 mV 
increments) to obtain a baseline measurement. After 1 minute, the perfusate was switched 
to a recording solution containing 100µM kainate (Abcam), 50µm APV (Sigma) and 1µM TTX 
(Sigma) and currents were elicited as above to obtain the currents in the presence of kainate.   
Access resistance was measured before and after all recordings and an access resistance >20 
MΩ resulted in exclusion of that recording.  Due to the high membrane resistance of OPCs (>1 
GΩ) during calcium current recordings, recordings were made without series resistance 
compensation. Series resistance in AMPA current recordings was compensated 60 - 80%. 
Measurements were made from each data file using Clampfit 10.5. 
 
2.9 Tissue preparation and immunolabelling 
2.9.1 Embryonic tissue preparation  
 
Female mice were mated overnight and examined the following morning for the presence of 
a vaginal plug, which was denoted embryonic day 0.5 (E0.5).  At the required gestational stage, 
pregnant mice were euthanized by CO2 exposure, the embryos removed and their brains and 
spinal columns removed.  Postnatal mice were terminally anesthetised with pentobarbitone 
(i.p 30mg/kg; Ilium) and perfusion fixed with 4% (w/v) paraformaldehyde (PFA; Sigma) in PBS 
at a rate of 9mL per minute for ~4 minutes.  The brain was removed and sliced into 2mm thick 
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coronal slices using a rodent brain matrix (Agar Scientific, Essex, UK), and the spinal cord was 
removed from the spinal column.  All tissue was immersion fixed in 4% PFA (w/v) in PBS for 
90 minutes at 21°C, before being cryo-protected in 20% (w/v) sucrose (Sigma) in PBS overnight 
at 4°C.  The following day, tissue was embedded in Tissue-Tek® Cryomolds (Sakura) with 
Cryomatrix gel (Thermo Fisher Scientific), frozen and stored at -80°C.   
2.9.2 Postnatal tissue preparation  
 
Mice were terminally anaesthetized with an intraperitoneal (i.p) injection of sodium 
pentobartbital (30mg/kg, Ilium) and then perfusion fixed with 4% (w/v)  paraformaldehyde 
(PFA; Sigma) in phosphate buffered saline (PBS).  Brains were cut into 2 mm-thick coronal 
slices using a 1 mm brain matrix (Kent Scientific) before being post-fixed in 4% (w/v) PFA in 
PBS at 21°C for 90 min. Tissue was cryoprotected in 20% sucrose (Sigma) in PBS and snap 
frozen in OCT (ThermoFisher) for storage at −80°C.   
2.9.3 Immunohistochemistry 
 
Thirty micrometre coronal brain cryosections were collected and processed as floating 
sections (as per (O'Rourke et al., 2016)).  Cryosections were exposed to primary antibodies 
diluted in blocking solution [10% (v/v) fetal calf serum and 0.1% (v/v) triton x100 in PBS] and 
incubated overnight at 4°C on an orbital shaker. Primary antibodies included rabbit anti-LRP1 
(1:500, ab92544, Abcam), goat anti-PDGFRα (1:100, AF1062, R&D Systems), rabbit anti-ASPA 
(1:200, AB97454, Abcam), rabbit-anti-LRP2 (1:100, AB76967, Abcam), rat-anti-GFP (1:2000, 
04404-26, Nacalaitesque)  rat anti-MBP (1:100, MAB386, Millipore), rabbit anti-OLIG2 (1:400, 
AB9610, Abcam),  mouse anti-PSANCAM (1:500, MAB5324, Millipore), mouse anti-RC2 (1:100, 
MAB5740, Millipore), mouse anti-GFAP (1:2000, 556327, BD Pharmigen), guinea-pig anti-IBA1 
(1:250, 234004, Synaptic Systems), mouse anti-CC1 (1:200, MABC200 Millipore), mouse anti-
NeuN (1:200, MAB377, Millipore) and mouse anti-parvalbumin (1:1000, MAB1572, Millipore).  
 43 
2.9.4 Immunocytochemistry  
 
Primary OPCs grown on glass 13mm glass coverslips were fixed in 4% PFA for 15 minutes at 
room temperature. The coverslips were then rinsed 3 times with PBS and the cells were then  
exposed to blocking solution containing the relevant antibodies and (as stated above).  
 
2.10 Cuprizone administration and Black gold staining 
Cuprizone powder (Sigma, C9012) was added to crushed mouse food (Barrastock) at a 
concentration of 0.2% w/w and changed every 2 days for 35 days.  Tissue from cuprizone fed 
mice was collect as stated above (Tissue Preparation and immunohistochemistry).   Thirty 
micrometre µm brain sections were cut using a Leica CM1860 UV cryostat into PBS then 
floated onto superfrost glass slides.  Once dry, the sections were rehydrated in milliQ for 3 
minutes.  MilliQ was removed and preheated (60°C) 0.3% Black Gold II stain (Millipore, AG105) 
was added to the slide and incubated in an oven at 60°C for 60 minutes. Slides were the 
removed from oven and rinsed twice with milliQ before a preheated 1% v/v sodium 
thiosulphate solution was added and incubated for 3 minutes at 60°C. The slides were then 
rinsed prior to dehydration using a series of graded alcohol steps then submerged in xylene 
(Sigma, 214736) for 3 minutes prior to being mounted using DPX mounting media (Sigma, 
06522)  
2.11 Microscopy and Statistical Analysis 
Fluorescently labelled sections were examined using an UltraView Spinning Disc Confocal 
microscope with Volocity Software (Perkin Elmer, Waltham, USA).  Images were collected as 
z stacks with 2μm spacing using standard excitation and emission filters for DAPI, FITC (Alexa 
Fluor-488), TRITC (Alexa Fluor-568) and CY5 (Alexa Fluor-647).  Images for quantification were 
collected using a 10x or 20x objective and images spanning each region of interest were 
stitched together using Volocity software. Images used to quantify cellular morphology were 
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collected using a 20x, 40x or 60x water objective.  Black gold stained sections were captured 
on a light microscope using a 2.5x objective and were stitched together using Adobe 
Photoshop CS6.  All images were analysed with Photoshop CS6 (Adobe, San Jose, USA) or 
Image J (NIH, Bethesda, Maryland).  
All images were analyzed with Photoshop CS6 (Adobe, San Jose, USA) or Image J (NIH, 
Bethesda, Maryland). Statistical comparisons were carried out using Prism (Graph Pad, La 















Chapter 3 – LRP1 Expression in the Developing and Adult CNS 
Some of the immunohistochemical data for this Chapter were collected out prior to 
commencing postgraduate studies, however additional data were generated during my PhD. 
Most of the data were analysed and the manuscript written after commencing my PhD.  
3.1 Introduction 
 
Low density lipoprotein receptor related protein 1 (LRP1) is one of the largest members of the 
low-density lipoprotein receptor family, and binds a large variety of ligands to influence a 
range of cellular behaviors [reviewed (Auderset et al., 2016b).  While LRP1 is best known for 
its ability to mediate endocytosis (Li, 2000; Pi et al., 2012), it can also operate as a co-receptor 
(Gopal et al., 2011), or recruit non-receptor tyrosine kinases to its intracellular domain to 
mediate intracellular signal transduction (Shi et al., 2009).  Furthermore LRP1 can undergo 
proteolytic cleavage, reminiscent of notch or the amyloid precursor protein cleavage, to 
generate a soluble extracellular fragment (Arnim et al., 2005; Selvais et al., 2011) or a free 
intracellular domain, which has been shown to enter the nucleus and influence gene 
transcription (May, 2002a; Kinoshita et al., 2003; Zurhove et al., 2008).  Utilizing these 
signaling mechanisms, LRP1 performs unique tissue-specific functions [reviewed (Lillis et al., 
2008)], and it is highly likely that it mediates cell-type specific functions in the central nervous 
system (CNS).   
 
LRP1 is widely expressed throughout the CNS.  The majority of research examining LRP1 
function in the brain has focused on its role in regulating amyloid precursor protein trafficking 
(Ulery et al., 2000; Pietrzik et al., 2002), amyloid  β clearance from the brain parenchyma 
[reviewed (Ramanathan et al., 2015)], and blood brain barrier permeability (Yepes et al., 
2003).  However LRP1 is also detected in mature neurons, particularly those of the entorhinal 
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cortex, hippocampus (Wolf et al., 1992) and cerebellum (Bu et al., 1994), and is critical for 
neuronal function.  The selective deletion of Lrp1 from differentiated neurons during mouse 
development, leads to behavioural and motor defects including hyperactivity, tremor and 
dystonia (May et al., 2004).  These effects are primarily due to the importance of LRP1 for 
regulating synaptic function, specifically at the post-synaptic density where it is thought to 
regulate the turnover and recycling of synaptic proteins (May et al., 2004; Nakajima et al., 
2013).  More recently LRP1 was also shown to mediate the chemo-attraction and -repulsion 
of sensory neuron growth cones in vitro (Landowski et al., 2016), and there is some evidence 
that LRP1 is expressed by astrocytes (Casse et al., 2012) , microglia (Zhang et al., 2017) and 
oligodendrocytes (Gaultier et al., 2009) in vitro, and by a sub population of radial glia in the 
embryonic mouse brain (Hennen et al., 2013). 
Studies reporting the expression of LRP1 in the CNS have often focused on a single stage of 
development, and examined gross regional expression or a single cell type, often in vitro 
(Auderset et al., 2016b).  Therefore, when reading the literature, it is unclear which cells within 
the CNS actually express this receptor, and which do not.  Recent microarray and RNA 
sequencing data have shown that Lrp1 mRNA is highly expressed by neurons, astrocytes and 
microglia, as well as oligodendrocyte progenitor cells (OPCs) and newly formed 
oligodendrocytes in the early postnatal brain, but indicate that it is down-regulated as the 
cells differentiate into mature myelinating oligodendrocytes (Cahoy et al., 2008; Zhang et al., 
2014).  This is the first indication that LRP1 may be expressed by oligodendrocyte lineage cells 
in the healthy nervous system, but has not been verified at the protein level.  Herein we 
characterise LRP1 expression within the developing and mature mouse brain and spinal cord.  
We report that LRP1 is expressed extensively throughout the CNS, being expressed at high 
levels by radial glia, neuroblasts, neurons, microglia, astrocytes and OPCs.  However LRP1 was 
not expressed by mature oligodendrocytes in the brain or spinal cord, and was not expressed 
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by parvalbumin-positive cortical interneurons – indicating that LRP1 is not generically 
expressed by all neural cell types.  
 
3.2 Results  
 
3.2.1 LRP1 is expressed in the developing and adult mouse brain 
 
The LRP1 protein is highly expressed in the brain (Bu et al., 1994).  However, the differential 
expression of LRP1 across development has not been investigated.  To determine the relative 
expression of LRP1 from embryonic to postnatal development, and into adulthood, we 
performed a western blot analysis to detect LRP1 in protein lysates generated from E13.5, P5, 
and P60 C57Bl6 mouse brain (n=3 mice per age).  A single 85kDa band was detected in each 
lysate, corresponding to the size of the beta chain of LRP1 (Figure 6a).  LRP1 expression was 
normalised to GAPDH expression levels (Figure 6a).  We found that LRP1 expression peaked 
during early postnatal brain development, before decreasing in adulthood (Figure 6b).  From 
these data it is not possible to determine whether cells within the postnatal CNS reduce their 
expression of LRP1 with age, or whether this is the result of the changing cellular composition 
of the brain over this time period.  To look at this more closely, and determine which cell types 
specifically express LRP1 in the CNS, we next undertook an immunohistochemical 
characterisation of LRP1 expression in the brain and spinal cord.   
 
3.2.2 LRP1 is highly expressed by radial glia in the developing CNS  
 
In the embryonic brain and spinal cord, radial glial cell marker-2 (RC2) is a protein that binds 
to intermediate filament proteins in the radial glial stem cells (Chanas-Sacré et al., 2000), 
allowing identification of their cell bodies as well as their processes that project outwards 








Figure 6: LRP1 is highly expressed in the brain  
Whole brain lysates from E13.5, P5 and P60 wildtype mice were collected. Western blot was 
performed to examine LRP1 expression in the embryonic (E), postnatal (P) and adult (A) 
mouse brain and GAPDH protein expression. (c) Quantification of band pixel intensity 
normalised to loading control (GAPDH) shows that LRP1 expression is significantly elevated in 
the postnatal brain compared to the embryonic (P=0.001) and adult (P=0.0004) brain. Results 
were compared using a one-way ANOVA with a Tukey’s post-hoc test, expressed as means ± 









were LRP1-positive (Figure 7a; 117 of 117 cells counted).  Similarly, at E15.5 100% of radial 
glia examined in the MGE of the brain (Figure 7c; n=125 cells counted), and in the spinal cord 
(Figure 7e, n=112 cells counted) expressed LRP1 throughout the cell.  At E18, LRP1+ cells 
continued to occupy the ventricular zone of the brain (Figure 7g).  While it was not possible 
to demonstrate LRP1 co-localisation with RC2 at the cell body, due to the down-regulation of 
RC2, LRP1 and RC2 were still present together within the processes of these cells (Figure 7g).  
These data suggest that LRP1 is expressed by radial glia in the brain and spinal cord, and is 
sustained throughout embryonic development.  Even at these early developmental stages it 
was already clear that LRP1 expression was not restricted to the radial glia, as the LRP1+ radial 
glia wrapped around and made contact with other LRP1+ cells (Figure 7e).   
 
3.2.3 LRP1 is highly expressed by GFAP+ astrocytes in the postnatal CNS  
 
Radial glia are only present during development, replaced by a population of neural stem cells 
in the subventricular zone (SVZ) of the lateral ventricles in the postnatal brain.  These neural 
stem cells share a number of markers that identify them as being closely related to astrocytes.  
For example, fibrous astrocytes and neural stem cells both express glial fibrillary acidic protein 
(GFAP) (Young et al., 2010).  GFAP+ cells in the SVZ of the adult brain likely comprise both of 
these cell populations, and were found to express LRP1 (Figure 8a; 33 of 33 cells counted).  
Furthermore GFAP+ fibrous astrocytes in the corpus callosum of the P5 mouse brain also 
expressed LRP1 in the soma and along their processes (Figure 8c; 73 of 73 cells counted), and 
this expression was retained in adulthood (Figure 8e; 99.20% ± 1.37%; avg ± std, n=3 mice).  
In the spinal cord of adult mice, essentially all fibrous astrocytes were LRP1-postive (Figure 
8g; 108 of 109 cells counted).  While the majority of astrocytes in the adult mouse cortex are 




Figure 7: LRP1 is expressed by radial glial in the developing brain and spinal cord  
Coronal and transverse sections of embryonic brain (E13.5 a, E15.5 c and E18 g) and spinal cord (E15.5 
e) were immunolabelled to detect radial glia (RC2, green) and LRP1 (red). The nuclear marker Hoechst 
33342 was used to label cell nuclei (blue). (b,d,f,h,j) secondary alone controls. White arrows represent 
cell bodies and yellow arrows represent co-localisation. Scale bar represents 17μm. SC= spinal cord.  
 
 
Figure 8: LRP1 is highly expressed by fibrous astrocytes  
Coronal and transverse sections of early postnatal (P5 a) and adult (P60) brain (c,g,i) and 
spinal cord (e) were immunolabelled to detect astrocytes (GFAP, green) and LRP1 (red). The 
nuclear marker Hoechst 33342 was used to label cell nuclei (blue). (b,d,f,h,j) secondary alone 
controls. White arrows represent cell bodies and yellow arrows represent co-localisation. 
Scale bar represents 17μm. CC= corpus callosum, SC= spinal cord, Ctx= cortex, 
SVZ=subventricular zone and LV= lateral ventricle. 
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fibrous astrocytes present in layer I of the motor cortex were LRP1-positive (Figure 8i; 46 of 
48 cells counted).  These data are consistent with microarray (Cahoy et al., 2008) and RNA 
sequencing (Zhang et al., 2014) data which indicate that Lrp1 mRNA can be detected in 
astrocytes in the early postnatal mouse brain. 
 
3.2.4 LRP1 is highly expressed by neuroblasts and neurons in the developing and adult CNS 
 
During development, neurons are the first cell type produced by radial glia.  At E13.5, E15.5 
and E18, PSA-NCAM+ neuroblasts are present throughout the telencephalon.  It is important 
to note that while all neural progenitors express PSA-NCAM, as well as a number of glial 
progenitors (Marmur et al., 1998).  This high density of neuroblasts in the MGE made 
quantification extremely difficult.  However, at E13.5 all PSA-NCAM+ cells examined in the 
MGE of the developing brain, were found to express LRP1 (57 of 57 cells counted; Figure 9a), 
and continued to express LRP1 at E15.5 (108 of 110 cells counted; Figure 9c, e) and E18 (111 
of 111 cells counted; Figure 9g).   
Many of these neuroblasts mature into functional neurons in the postnatal CNS, and the fact 
that LRP1 is expressed by neurons is well established (May et al., 2004; Lillis et al., 2008; Liu 
et al., 2010).  NeuN is a perinuclear protein expressed by the majority of mature CNS neurons, 
including all excitatory neurons (Mullen et al., 1992).  We determined that LRP1 was expressed 
by essentially all NeuN+ neurons in the P5 mouse cortex (111 of 113 NeuN+ cells counted; 
Figure 10a).  Furthermore 98.44% ± 0.99% of NeuN+ cells expressed LRP1 in the adult mouse 
cortex (Figure 10c; n=3 mice, avg ± std).  Similarly in the spinal cord grey matter 97.7% ± 0.76% 
of NeuN+ neurons expressed LRP1 (Figure 10e; n=3 mice, avg ± std).  However not all neurons 
express NeuN.  Interneurons are the GABAergic inhibitory neurons of the CNS, and they 




Figure 9: Neuroblasts express LRP1 in the embryonic brain and spinal cord  
Coronal and transverse sections of embryonic brain (E13.5 a, E15.5 c and E18 g) and spinal 
cord (E15.5 e) were immunolabelled to detect neuroblasts (PSANCAM, green) and LRP1 
(red). The nuclear marker Hoechst 33342 was used to label cell nuclei (blue). (b,d,f,h,j) 
secondary alone controls. White arrows represent cell bodies and yellow arrows represent co- 




Figure 10: NeuN-positive neurons express LRP1, but not parvalbumin-positive interneurons  
Coronal sections of early postnatal (P5, a) and adult (P60, c) brain and spinal cord (e) were 
immunolabelled to detect mature neurons (NeuN, green) and LRP1 (red), as well as a 
subpopulation of interneurons (parvalbumin, green, e). The nuclear marker Hoechst 33342 
was used to label cell nuclei (blue). (b,d,f,h) secondary alone controls. White arrows represent 
cell bodies and yellow arrows represent co-localisation. Scale bar represents 17μm. Ctx= 
cortexand SC= spinal cord.  
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which do not express NeuN (Clarke et al., 2012).  However, in the cortex a large proportion of 
interneurons, specifically the chandelier and basket cells, can be identified by their expression 
of the calcium binding protein parvalbumin (Kawaguchi and Kubota, 1987).  To determine 
whether interneurons also express LRP1, we processed P60 mouse brain cryosections to 
detect LRP1 and parvalbumin (Figure 10g), and were surprised to find that only 3.02% ± 2.68% 
of parvalbumin+ interneurons expressed LRP1 (n=3 mice, avg ± std).  These data indicate that 
LRP1 does not play a generic role in regulating neuron function in the CNS, and is not required 
for the normal functioning of parvalbumin-positive interneurons.   
 
3.2.5 LRP1 is highly expressed by microglia in the CNS 
 
Microglia are the resident immune cells of the CNS and act as the first line of defence against 
CNS damage.  Following an event such as CNS injury or infection, microglia alter their 
morphology and function to a proinflammatory, phagocytic state which allows for the 
clearance of cellular debris and invading pathogens (Kim and de Vellis, 2005).  Lrp1 mRNA has 
been previously shown to be highly expressed in microglia (Cahoy et al., 2008; Zhang et al., 
2014) and LRP1 has also been shown to be expressed by microglia in vitro (Jeon et al., 2012; 
Zhang et al., 2017).  To determine whether microglia express LRP1 across development and 
during adulthood we performed immunohistochemistry on coronal mouse brain and 
transverse spinal cord cryosections to detect LRP1 (red) and the specific marker of activated 
microglia, Iba-1 (Ito D et al., 1998) (green) (Figure 11).  Microglia were readily detected in the 
CNS at all ages, and strongly expressed LRP1 at E13.5 (Figure 11a), E15.5 (Figure 11c), E18 
(Figure 11e), P5 (Figure 11g, i) and P60 (Figure 11k, m).  Quantification of the proportion of 
microglia that express LRP1 revealed that ~96-98% of brain microglia expressed LRP1 at each 









Figure 11: Microglia in the brain stably express LRP1 throughout life  
Coronal sections of embryonic (E13.5 a, E15.5 c and E18 e), early postnatal (P5, g,i) and adult 
(P60, k,m) brain were immunolabelled to detect microglia (Iba1, green) and LRP1 (red). The 
nuclear marker Hoechst 33342 was used to label cell nuclei (blue). (o) The percentage of Iba1+ 
cells that also expressed LRP1 remained high across all time points examined. Results were 
compared using a one-way ANOVA with a Bonferroni’s post-hoc test, expressed as means ± 
SEM and are representative of three independent experiments. (b,d,f,h,j,l,n) secondary alone 
controls. White arrows represent cell bodies and yellow arrows represent co- localisation. 










Figure 12: Microglia in the spinal cord express high levels of LRP1  
Transverse sections of embryonic (E15.5, a) and adult (P60, c) spinal cord were immunolabelled to 
detect microglia (Iba1, green) and LRP1 (red). The nuclear marker Hoechst 33342 was used to label 
cell nuclei (blue). (b,d) secondary alone controls. White arrows represent cell bodies and yellow 







cord also expressed LRP1.  In fact the proportion of microglia that express LRP1 in the brain 
and spinal cord was remarkably similar, with 98.66 ± 1.33% of microglia in the adult spinal 
cord labelling with anti-LRP1 (n=3 mice, avg ± std).  These data demonstrate that microglia 
consistently express LRP1 throughout development.  
3.2.6 LRP1 is expressed by OPCs, but not oligodendrocytes in the CNS 
 
As their name suggests, oligodendrocyte progenitor cells (OPCs) are immature cells that give 
rise to the myelin-forming oligodendrocytes in the developing and adult CNS.  In the mouse, 
the majority of oligodendrocytes are born in the first month following birth, however the life-
long addition of new oligodendrocytes has been implicated in CNS repair as well as learning 
and memory [reviewed (Wang and Young, 2014)].  A recent RNA sequencing study indicated 
that Lrp1 mRNA was highly expressed by OPCs, but not by oligodendrocytes (Zhang et al., 
2014).  However, the expression of LRP1 protein by OPCs or oligodendrocytes has never been 
reported.   
To determine whether OPCs express LRP1 we processed cryosections to detect platelet-
derived growth factor receptor α (PDGFRα; green), a protein uniquely expressed by OPCs 
within the CNS (Richardson et al,. 1988), and LRP1 (red) (Figure 13).  By E15.5 a chain of 
PDGFRα+ OPCs extended from the MGE to the developing cortex, and ~70% of them were 
found to express LRP1 (Figure 13a, l).  By E18, OPCs had populated the entire CNS (Kessaris et 
al., 2005), and the proportion that labelled with anti-LRP1 increased to ~83% (Figure 13c, l).  
Furthermore, LRP1 expression was detected in the cell soma, and throughout the processes 
(Figure 13c).  In the P5 mouse brain, ~98% of OPCs in the corpus callosum (Figure 13e, l) and 
~99% of OPCs in the cortex (Figure 13g, l) labelled with anti-LRP1.  Similarly, at P60, ~99% of 
OPCs expressed LRP1 in the corpus callosum (Figure 13g) and cortex (Figure 13i).  The fraction 







Figure 13: LRP1 is developmentally upregulated on OPCs  
Coronal sections of embryonic (E15.5 a and E18 c), early postnatal (P5, e,i) and adult (P60, 
k,m) brain were immunolabelled to detect oligodendrocyte progenitor cells (Pdgfrα, green) 
and LRP1 (red). The nuclear marker Hoechst 33342 was used to label cell nuclei (blue). 
(b,d,f,h,j) secondary alone controls. (k) The percentage of OPCs that express LRP1 was 
significantly less in the embryonic brain. Results were compared using a one-way ANOVA with 
a Bonferroni’s post-hoc test, expressed as means ± SEM and are representative of three 
independent experiments. *=P<0.05, ****=P<0.0001. Scale bar represents 17μm. CC= corpus 




relative to both postnatal time points examined (Figure 13k; one-way ANOVA with 
Bonferroni).  These differences may be due to the proportion of OPCs present from specific 
germinal zones at the time of analysis, for example at E15 OPCs derived from the MGE and 
AEP may not express LRP1, but as this population dies shortly after birth (Kessaris et al., 2005), 
the percentage of OPCs that express LRP1 increases.  The proportion of OPCs that expressed 
LRP1 in the embryonic and postnatal brain, was mirrored in the spinal cord, with only 77.11% 
± 0.72% of OPCs expressing LRP1 at E15.5 (n=3 mice, avg ± std; Figure 14a), but 100% ± 0% of 
spinal cord OPCs expressing LRP1 by adulthood (n=3 mice, avg ± std; Figure 14c).  These data 
suggest that OPCs acquire LRP1 expression during development, but then retain this 
expression throughout postnatal life.   
Individual OPCs appeared to express a high level of LRP1 protein by immunohistochemistry.  
To examine this directly, we determined the maximum pixel intensity for LRP1 at the microglia 
(236 ± 8.37 arbitrary units, mean ± SEM, n=19 cells), OPC (208 ± 12.24 arbitrary units, mean ± 
SEM, n=14 cells) and neuronal somas (125 ± 6.68 arbitrary units, mean ± SEM, n=14 cells) in 
the P60 mouse cortex.  Microglia and OPCs expressed an equivalent level of LRP1, while NeuN+ 
neurons expressed significantly less LRP1 than both of these cell types (p<0.05, Kruskal-
Wallis).   
When OPCs mature into oligodendrocytes they no longer express PDGFRα.  Therefore, the OL-
specific antibody CC1 (Bhat et al,. 1996), also known as APC, was used to label 
oligodendrocytes in the P60 mouse corpus callosum and spinal cord white matter (Figure 15).  
Oligodendrocytes in the corpus callosum assemble themselves in series, running parallel with 
the axons that traverse the two cerebral hemispheres.  We found that 0.0% ± 0.0% of CC1+ 











Figure 14: OPCs in the spinal cord express LRP1 in the cell body and processes  
Transverse sections of embryonic (E15.5, a) and adult (P60, c) spinal cord were 
immunolabelled to detect oligodendrocyte progenitor cells (Pdgfrα, green) and LRP1 (red). 
The nuclear marker Hoechst 33342 was used to label cell nuclei (blue). (b,d) secondary alone 
controls. White arrows represent cell bodies and yellow arrows represent co-localisation. 























Figure 15: Oligodendrocytes do not express LRP1  
Coronal and transverse sections of adult (P60) brain (a) and spinal cord (c) were 
immunolabelled to detect oligodendrocytes (CC1, green) and LRP1 (red). The nuclear marker 
Hoechst 33342 was used to label cell nuclei (blue). (b,d) secondary alone controls. White 
arrows represent cell bodies and yellow arrows represent co-localisation. Scale bar 





none of CC1+ cells in the spinal cord expressed LRP1 (122 cells counted).  These data indicate 
that oligodendrocytes do not require LRP1 for their CNS function.   
 
3.2.7 Newly formed oligodendrocytes do not express LRP1 
 
Given that OPCs highly expressed LRP1, but oligodendrocytes did not, we wanted to 
determine the point in oligodendrocyte maturation when LRP1 was down-regulated.  RNA 
sequencing data suggest that Lrp1 mRNA is expressed by OPCs, but is still present, albeit at a 
lower level, in newly formed oligodendrocytes (Zhang et al., 2014).  To look at this more closely 
we performed cre-lox transgenic lineage tracing of OPCs in adulthood.  Pdgfra-CreERT2 :: 
Rosa26-YFP mice were given tamoxifen at P57 to turn on YFP expression in PDGFRα+ OPCs.  
Mice were perfusion fixed one week later and coronal brain sections processed to detect YFP, 
LRP1 and either PDGFRa or CC1.  As expected, we found that YFP+ PDGFRa+ OPCs in the corpus 
callosum had given rise to YFP+ PDGFRa-negative newborn oligodendrocytes in the one week 
tracing period (Rivers et al., 2008; Kang et al., 2010b).  Consistent with our earlier data, all 
YFP+ PDGFRa+ OPCs expressed LRP1 (Figure 16a, 100% ± 0%, n=3 mice) and all YFP+ CC1+ 
oligodendrocytes did not express LRP1 (Figure 16b, 0% ± 0%; avg ± std, n=3 mice).  
Furthermore, all YFP+ PDGFRa-negative newborn oligodendrocytes were LRP1-negative 
(Figure 16c).  Therefore LRP1 protein expression is not retained by any new YFP-labelled 
oligodendrocytes, even in a population that would comprise both premyelinating and 
myelinating cells.  These data strongly indicate that LRP1 is rapidly down-regulated alongside 
PDGFRa at the onset of differentiation and is not retained beyond the progenitor stage in the 





Figure 16. Newly formed oligodendrocytes do not express LRP1.  
Tamoxifen was administered to Pdgfra-CreERT2:: Rosa26-YFP transgenic mice at P57 to label 
OPCs and trace them as they generate new oligodendrocytes until P64. Single scan confocal 
images were collected through the corpus callosum (CC) following immunolabelling with YFP 
(green), LRP1 (red) and either PDGFRα or CC1 (blue). a-a”‘ YFP+, PDGFRα+ cells were also 
LRP1+. b-b”‘ YFP+, PDGFRα-negative cells were also negative for LRP1. c-c”‘ YFP+ CC1+ cells 
were found to be LRP1-negative. White arrows indicate regions of co-localisation. 
Arrowheads indicate oligodendrocyte cell bodies, which do not express LRP1. Scale bars 






Our data indicate that LRP1 protein is present in the brain of embryonic, early postnatal and 
adult mice.  Specifically, LRP1 is expressed by radial glia, immature and mature neurons, 
excluding parvalbumin-positive interneurons, and is also expressed by microglia, astrocytes 
and OPCs, but not newly formed and mature oligodendrocytes.  These data are largely 
consistent with previously published microarray and RNA sequencing studies comparing the 
expression of Lrp1 mRNA by neurons, microglia, astrocytes and oligodendrocyte-lineage cells 
(Cahoy et al., 2008; Zhang et al., 2014) with the exception of newly formed oligodendrocytes.  
The absence of LRP1 expression from oligodendrocytes may also contribute to the overall 
decrease in LRP1 expression detected in the brain between P5 and P60.  Oligodendrocytes are 
largely generated after P5 in the mouse, and while this is unlikely to be the sole explanation, 
it would certainly be a contributing factor. 
 
3.3.1 Neuronal populations differentially express LRP1 in the mature CNS 
 
Given that LRP1 has been implicated in neuronal development (Landowski et al., 2016), it is 
not surprising that we observed a high level of LRP1 expression in immature neurons in the 
embryonic CNS.  However by the time the neurons matured into NeuN+ or parvalbumin+ 
neurons there was a clear divergence in LRP1 expression, with NeuN+ neurons expressing LRP1 
while parvalbumin+ neurons did not.  Parvalbumin-positive interneurons comprise 
approximately 40% of interneurons in the mature mouse cortex (Rudy et al., 2010), and 
include interneuron subtypes such as basket and chandelier cells (Kawaguchi and Kubota, 
1997).  While this is the first study to examine the expression of LRP1 in parvalbumin-positive 
interneurons, a previous study did report LRP1 expression in somatostatin-positive 
interneurons in the hippocampus and parietal cortex (Van Uden et al., 1999).  Somatostatin-
positive interneurons comprise approximately 30% of interneurons in the mature mouse 
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cortex (Rudy et al., 2010), and are made up predominately of Martinotti cells as well as a small 
number of X94 cells (Kawaguchi and Kubota, 1997; Ma, 2006).  We hypothesised that LRP1 
may be expressed by somatostatin+ but not parvalbumin+ interneurons, due to their distinct 
developmental origins.  Parvalbumin-positive interneurons arise from Nkx2.1-expressing 
precursors in the MGE, while the somatostatin-positive interneurons arise from the Nkx6.2 
expressing precursors in the dorsal MGE (Butt et al., 2005; Fogarty et al., 2007).  However this 
is unlikely to be the reason why parvalbumin+ interneurons do not express LRP1, as 
neuroblasts arising from the MGE at each embryonic stage examined, were LRP1-positive.  
Therefore, these neurons must downregulate LRP1 upon differentiation, suggesting instead 
that parvalbumin+ interneurons do not require LRP1 for their function.  
We report that LRP1 is consistently expressed by NeuN-positive neurons throughout the 
cortex and spinal cord.  These data are consistent with previous studies reporting that LRP1 
expression is particularly pronounced in the cell body and proximal processes of cortical and 
CA1 pyramidal  neurons  (Wolf et al., 1992; Bu et al., 1994; May et al., 2004), which are 
neuronal populations known to express NeuN.  While this study does not examine the 
functional role of LRP1 in these neuronal populations, the conditional deletion of Lrp1 from 
forebrain neurons in vivo previously revealed that LRP1 is important for synapse maintenance, 
as its absence resulted in synaptic loss and neurodegeneration.  This was largely attributed to 
impaired lipid metabolism (Liu et al., 2007; 2010).  However in vitro studies also indicate that 
LRP1 interacts with post-synaptic receptors, and can thereby regulate synaptic function 
(Maier et al., 2013; Nakajima et al., 2013; Gan et al., 2014).  
  
3.3.2 LRP1 as a critical regulator of microglia in the CNS 
 
The consistent and high level of LRP1 expression that we observed in microglia at all ages 
examined, points to this receptor playing an important role in this cell type across the life-
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span.  Previous studies have shown that LRP1 is expressed in primary microglial cultures 
derived from rats (Marzolo et al., 2000) and mice (Pocivavsek et al., 2009).  However, what 
could be the function of LRP1 in regulating microglial function?  In vitro, the transition of 
microglia from a “resting” or surveillance state to an “activated” or pro-inflammatory state 
can be triggered by activation of LRP1 by one of its ligands, tissue plasminogen activator (tPA), 
and this same ligand was found to promote the migration of microglia-like BV-2 cells (Jeon et 
al., 2012).  In vivo, when Lrp1 was conditionally ablated from microglia, the cells were less 
responsive to cerebral ischemia (Zhang et al., 2017).  However regulating activation and 
migration may not be the only microglial functions regulated by LRP1, as the knockdown of 
Lrp1 in vitro, using siRNA, reduced their phagocytic capacity, decreasing their internalisation 
of amyloid β (N'songo et al., 2013).  These data indicate that LRP1 may be important for the 
initial activation of microglia, followed by migration to the site of injury and the subsequent 
clearing of cellular debris or foreign pathogens.  However how LRP1 differentially regulates 
these functions is far from understood.   
 
3.3.4 What is the function of LRP1 in astrocytes?  
 
LRP1 expression was observed in astrocytes at each postnatal age examined.  These data are 
consistent with previous findings that demonstrated LRP1 is expressed by human cerebral and 
cerebellar astrocytes (Moestrup et al., 1992) ,  rat astrocytes (Bu et al., 1994) and mouse 
primary astrocyte cultures  (Marzolo et al., 2000).  Lrp1 mRNA has also been shown to be 
present in mouse astrocytes (Zhang et al., 2014).  The role that LRP1 plays in regulating 
astrocytic function has not been extensively studied.  However one potential function is that 
LRP1 regulates the availability of its ligand, tissue plasminogen activator, at the synapse by 
facilitating clathrin dependant endocytosis (Casse et al., 2012).  Additionally, LRP1 is expressed 
by perivascular astrocytes, and may be involved in the regulation of blood brain barrier 
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permeability in the early stages of cerebral ischemia (Samson et al., 2008).  Given the diverse 
range of functions that astrocytes perform, and the high level of LRP1 that we detect in these 
cells, further investigation into the function of LRP1 in this cell type would be warranted.   
 
3.3.5 What is the function of LRP1 in OPCs? 
Our data raise a number of questions relating to the role played by LRP1 in regulating the 
behaviour of OPCs.  A previous study examining cultured neurospheres found that upon 
differentiation, cultures that lacked Lrp1 produced significantly fewer oligodendrocytes 
compared to control neurospheres (Hennen et al., 2013).  The authors suggested that these 
data reflected a critical role for LRP1 in regulating the generation of OPCs from neural stem 
cells.  However, an equally plausible explanation could be that LRP1 is required for the 
expansion of OPCs or their differentiation into oligodendrocytes.   
OPCs are continuously producing new oligodendrocytes throughout life (Dimou et al., 2008; 
Rivers et al., 2008; Kang et al., 2010b; Zhu et al., 2011; Young et al., 2013), and in young adult 
mice, the rate of oligodendrogenesis is still remarkably high (Rivers et al., 2008).  By tracing 
the fate of OPCs using a transgenic reporter mouse, we were able to selectively identify 
newborn oligodendrocytes that were born during the one week tracing period.  We found that 
the YFP-labelled newborn oligodendrocytes (PDGFRα-negative cells) were devoid of LRP1 
expression.  Furthermore, no CC1+ oligodendrocytes expressed LRP1.  Our observation that 
newly formed oligodendrocytes did not express LRP1 was surprising due to the moderately 
high Lrp1 mRNA levels identified by RNA sequencing (Zhang et al., 2014), and indicate that the 
mRNA levels do  not necessarily correlate with protein abundance [reviewed  (Vogel and 
Marcotte, 2012)].  The rapid down-regulation of LRP1 following OPC differentiation 
demonstrates that LRP1 is only necessary for normal function in OPCs, and that its expression 
is not required for oligodendrocyte maturation.  Given that LRP1 expression in OPCs appears 
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to co-localise strongly with PDGFRα (Figure 16 a’-a’’), it is possible that these receptors form 
a signalling complex and the loss of PDGFRα is accompanied by a down-regulation in LRP1 
expression.  There is some foundation for speculating that LRP1 may interact with PDGFRα, as 
it has been previously shown to interact with the related PDGFRβ in fibroblasts cell lines 
(Newton et al., 2005; Takayama et al., 2005; Craig et al., 2013).  However the role of LRP1 in 




LRP1 protein is present in the brain of embryonic, early postnatal and adult mice.  On a cellular 
level, LRP1 is highly expressed by some glial and neuronal cell populations.  In particular, LRP1 
is expressed by radial glia, immature and mature neurons (excluding parvalbumin-positive 
interneurons), microglia, astrocytes and OPCs.  However, LRP1 is down-regulated early in OPC 
differentiation, as LRP1 is not expressed by newly formed or mature oligodendrocytes.  
Overall, these data indicate that CNS glia are highly susceptible to LRP1 signalling, a possibility 




























Chapter 4 - LRP1 is a negative regulator of oligodendrocyte 




4.1 Introduction  
Oligodendrocytes myelinate the central nervous system (CNS) to facilitate the rapid and 
reliable propagation of action potentials along axons, and to provide axons with essential 
metabolic support [reviewed by (Philips and Rothstein, 2017)].  While the majority of OLs are 
produced during development, new OLs are continuously produced from oligodendrocyte 
progenitor cells (OPCs)  (Dimou et al., 2008; Rivers et al., 2008; Zhu et al., 2008; Kang et al., 
2010a; Hughes et al., 2013; Young et al., 2013; Hill et al., 2018), and add myelin internodes to 
the CNS throughout life (Hill et al., 2018; Hughes et al., 2018).  A number of signalling pathways 
have been identified that regulate different aspects of developmental and adult OPC 
behaviour, and oligodendrogenesis, including pathways involving Notch1 (Genoud et al., 
2002; Givogri et al., 2002; Zhang et al., 2009), fibroblast growth factor 2 (Murtie et al., 2005; 
Zhou et al., 2006; Murcia-Belmonte et al., 2014), mammalian target of rapamycin (Zou et al., 
2014; Jiang et al., 2016; Grier et al., 2017) and platelet-derived growth factor A (McKinnon, 
2005; Rajasekharan, 2008; Chew et al., 2010).  However, microarray (Cahoy et al., 2008) and 
RNA sequencing (Zhang et al., 2014; Hrvatin et al., 2018) experiments have uncovered a 
number of  mRNA transcripts that are differentially expressed across oligodendrocyte 
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development, but have no known regulatory function in this lineage.  One such gene is the 
low-density lipoprotein receptor related protein 1 (Lrp1). 
LRP1, also known as CD91, or the α2 macroglobulin receptor (α2MR), is highly expressed by 
OPCs, and is rapidly downregulated with OL differentiation (Auderset et al., 2016a).  This large 
cell surface receptor, comprising a 515kDa extracellular α-chain and an 85kDa β-chain, can 
interact with a large variety of ligands, as well as extracellular and intracellular proteins 
(reviewed by (Bres and Faissner, 2019).  Consequently, LRP1 can signal in a variety of ways 
including ligand endocytosis and processing (Cam et al., 2005; Parkyn et al., 2008; Liu et al., 
2017; Van Gool et al., 2019), receptor trafficking (Parkyn et al., 2008; Maier et al., 2013; 
Kadurin et al., 2017) and cleavage and formation of a soluble product (May, 2002b; Liu et al., 
2009; Brifault et al., 2017; 2019).  Lrp1 knockout is embryonic lethal due to a failure in 
blastocyst implantation (Herz et al., 1992) and the conditional deletion of Lrp1 from cultured 
mouse neural stem and progenitor cells (NSPCs) has been shown to impair NSPC proliferation 
and reduce the number of oligodendrocyte lineage cells they produce (Hennen et al., 2013; 
Safina et al., 2016).  Furthermore, the conditional deletion of Lrp1 from Olig2+ cells in 
development (Olig2-Cre :: Lrp1fl/fl mice) impairs oligodendrogenesis and myelination in the 
optic nerve by postnatal day 21 (Lin et al., 2017).    
OPC physiology changes considerably between development and adulthood and can also 
differ between CNS regions (Velez-Fort et al., 2010; Pitman et al., 2020; Spitzer et al., 2019). 
Therefore, to explore the potential role that LRP1 plays in adult OPCs, we employed a 
conditional gene deletion approach to evaluate the capacity for LRP1 to regulate OPC 
behaviour and oligodendrogenesis in the adult mouse brain.  We report that LRP1 is a negative 
regulator of OPC differentiation in the healthy CNS and that Lrp1 deletion prior to cuprizone 
induced demyelination results in smaller lesions.  
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4.2 Results  
4.2.1 LRP1 can be successfully deleted from OPCs in the adult mouse brain  
 
In order to determine the role that LRP1 plays in regulating adult myelination, Lrp1 was 
conditionally deleted from OPCs in young adult mice.  Tamoxifen was administered to P50 
control (Lrp1fl/fl) and Lrp1-deleted (Pdgfrα-CreERTM :: Lrp1fl/fl) mice and brain tissue examined 
7 or 30 days later (at P50+7 and P50+30, respectively).  Coronal brain cryosections from 
control (Fig. 17a) and Lrp1-deleted mice (Fig. 17b) were immunolabelled to detect LRP1 (red) 
and OPCs (PDGFRa, green).  Consistent with Auderset et al. (2016), essentially all OPCs in the 
corpus callosum of control mice expressed LRP1 (Fig. 17c: P50+7, 99% ±  0.6%; P50+30, 99.7% 
±  0.3%).  However, in the corpus callosum of P50+7 Lrp1-deleted mice, only 2% ± 0.8% of 
PDGFRα+ OPCs expressed LRP1, and at P50+30, only 0.5% ± 0.5 of OPCs expressed LRP1 (Fig. 
17c), confirming the successful deletion of Lrp1 from adult OPCs.  Similar results were found 
in the motor cortex at P50+7, with 100% ± 0% of PDGFRa+ also expressing LRP1 in control 
mice, while only 0.4% ± 0.4% of PDGFRa+ cells in the Lrp1 deleted mice expressed LRP1.  
Deletion of the extracellular portion of the Lrp1 gene was also confirmed by PCR, as gene 
deletion enabled the amplification of a recombination-specific DNA product from genomic 
DNA extracted from Lrp1-deleted brain tissue that was not amplified from control mouse 
genomic DNA (Fig. 17d).   
4.2.2 Lrp1-deletion increases adult OPC proliferation 
 
OPCs divide more frequently in white matter than grey matter regions of the adult mouse CNS 
(Psachoulia et al., 2009), and it has been reported that adult OPCs divide to self-renew, 
ensuring the homeostatic maintenance of a stable pool of cells (Hughes et al., 2013).  To 








Figure 17: LRP1 can be deleted from the vast majority of OPCs   
Coronal brain sections from P57+7 and P57+30 control (Pdgfra-CreERTM) and Lrp1-deleted 
(Pdgfra-CreERTM :: Lrp1fl/fl ) mice were immunolabelled to detect OPCs (PDGFRa, green) and 
LRP1 (red).  (a) Confocal image of LRP1+ OPCs in the corpus callosum (CC) of a P50+7 control 
mouse (yellow arrow heads).  (b) Confocal image of LRP1-neg OPCs in the CC of a P50+7 Lrp1-
deleted mouse (white arrow heads).  (c) The proportion (%) of PDGFRa+ OPCs that express 
LRP1 in P50+7 and P50+30 control and Lrp1-deleted mice (n=3-4 mice per genotype per time-
point; [2-way ANOVA genotype F (1,10)=2.8, p = <0.0001; days post tamoxifen (F 1,10) =0.52, 
p = 0.5; interaction F(1, 10)= 3.44, p = 0.09] with Bonferroni multiple comparisons, **** p ≤ 
0.0001).  (d) PCR amplification of genomic DNA from the brain of P50+7 control (Pdgfra-
CreERTM) and Lrp1fl/fl (Pdgfra-CreERTM :: Lrp1fl/fl) mice indicates that recombination (producing 
the Lrp1 reco band) only occurs in Lrp1fl/fl mice.  The nuclear marker Hoescht 33342 was used 













of OPCs that proliferate, we delivered a thymidine analogue, EdU, to P57+7 control and Lrp1-
deleted mice, via the drinking water, for 2, 4, 6 or 20 days.  Coronal brain cryosections from 
control (Fig. 18a-d) and Lrp1-deleted (Fig. 18e-h) mice were processed to detect PDGFRα+ 
OPCs (green) and EdU (red).  When quantifying the proportion of OPCs that became EdU 
labelled over time, we found that 20 days of EdU-delivery resulted in EdU uptake by all OPCs 
in the corpus callosum of control and Lrp1-deleted mice (100% ± 0% and 100% ± 0% 
respectively; Fig. 18d, h), indicating that the proportion of OPCs that can proliferate is not 
influenced by LRP1 signalling.  Furthermore, the rate of EdU incorporation by OPCs was 
equivalent in the corpus callosum of control or Lrp1-deleted mice (Fig. 18i), suggesting that 
LRP1 does not influence the rate at which OPCs enter the cell cycle and become labelled.  
While OPCs in the motor cortex entered the cell cycle less frequently than those in the corpus 
callosum i.e. EdU labelling occurred at a slower rate (compare the slope of the regression lines 
in Fig. 18i and Fig. 18j), OPC proliferation in the motor cortex was also not affected by Lrp1-
deletion (Fig. 18j). 
While these data indicate that LRP1 does not influence OPC proliferation immediately after 
deletion, one potential function of LRP1 can be the delivery or removal of signalling receptors 
and channels to the cell membrane (Takayama et al., 2005; Liu et al., 2010; Pi et al., 2012; 
Maier et al., 2013; Nakajima et al., 2013) - a function that, if disrupted, may take time to have 
adverse effects on OPC behaviour.  To explore this possibility, we delivered tamoxifen to 
young adult (P57) control and Lrp1-deleted mice and waited a further 28 days before 
administering EdU via the drinking water for 4 consecutive days.  Coronal brain cryosections 
were collected from P57+32 control (Fig. 18k) and Lrp1-deleted (Fig. 18l) mice and processed 
to detect PDGFRα+ OPCs (green) and EdU (red).  The proportion of OPCs that incorporated 
EdU over the 4-day labelling period was significantly higher in the corpus callosum of Lrp1-





Figure 18: Lrp1 deletion leads to a delayed change in OPC proliferation  
Coronal brain sections from control (Pdgfra-CreERTM) and Lrp1 deleted mice (Pdgfra-
CreERTM:: Lrp1fl/fl) were immunolabelled to detect OPCs (PDGFRa, green) and EdU (red). (a-h) 
Confocal images showing EdU labelled OPCs in the corpus callosum after 2,4,6 and 20 days of 
EdU exposure. Graphical representation of the rate of EdU incorporation into OPCs in the 
corpus callosum (i, p=0.7, n= minimum of 3 mice per timepoint; m= 9.2 ± 1.80 and R2 = 0.71 
for control and m= 10.2 ± 1.77 and R2 = 0.81 for Lrp1-del) and motor cortex (j p=0.3 ,n= 
minimum of 3 mice per timepoint; m= 2.9 ± 0.26 and R2 = 0.92 for control and m= 3.4 ± 0.32 
and R2 = 0.88 for Lrp1-del).  Coronal brain sections from control  (k,Pdgfra-CreERTM) and Lrp1-
deleted (l,Pdgfra-CreERTM:: Lrp1fl/fl) mice that received EdU via the drinking water for  4 
consecutive days (from P57+28) were immunolabelled to detect OPCs (PDGFRa, green) and 
EdU (red). (m) graphical representation showing the percentage of EdU+ OPCs in the corpus 
callosum (mean ±SD, n=3 mice per genotype; unpaired t-test, p=0.008 ).  (n) Quantification 
of the density of OPCs in the CC of P57+28 control and Lrp1fl/fl mice (mean ±SD, n=3 mice per 
genotype; unpaired t-test, p= 0.6). Scale bar represents 17µm (a-h) and 70µm (k,l) White 





by a change in the density of PDGFRa+ OPCs, which was equivalent in the corpus callosum of 
control and Lrp1-deleted mice (Fig. 18n).  These data suggest that Lrp1 deletion from adult 
OPCs results in a delayed increase in OPC proliferation, that must be accompanied by an 
increase in new OL generation i.e. OPC differentiation, or an increase in the number of 
newborn cells that die.  
 
4.2.3 LRP1 is a negative regulator of adult oligodendrogenesis  
 
An increase in OPC proliferation without a change in OPCs density could be the result of 
enhanced OPC differentiation.  To determine whether LRP1 regulates OL production by adult 
OPCs, tamoxifen was given to P57 control (Pdgfrα-CreERTM :: Rosa26-YFP) and Lrp1-deleted 
(Pdgfrα-CreERTM :: Rosa26-YFP :: Lrp1fl/fl) mice, to fluorescently label adult OPCs and the new 
OLs they produce.  Coronal brain cryosections were generated from P57+14 mice and 
immunolabeled to detect YFP (green), PDGFRa (red) and OLIG2 (blue) and confirmed the 
specificity of labelling by demonstrating that YFP+ cells were cells of the oligodendrocyte 
lineage (Fig. 19).  Consistent with our previous findings in control mice (O’Rourke et al., 2016), 
all YFP+ cells in the corpus callosum were either PDGFRα+ OLIG2+ OPCs or PDGFRα-negative 
OLIG2+ newborn OLs (in control mice: 100% ± 0% of YFP+ cells were OLIG2+; In Lrp1-deleted 
mice; 100% ± 0% YFP+ cells were OLIG2+; avg ± SD for n=3 mice per genotype; Fig. 19c).  In the 
motor cortex of P57+14 control and Lrp1-deleted mice, essentially all YFP+ cells were also 
found to be OLIG2+ (avg ± SD for n=3 mice per genotype; 96.2% ± 0.91 and 94.3% ± 1.02 
respectively).  The small number of YFP+ OLIG2-negative cells identified in the cortex were 
neurons (data not shown), and these YFP+ OLIG2-negative cells were excluded from all 




Figure 19: Almost all YFP labelled cells are of the oligodendrocyte lineage. 
Coronal brain sections were taken from control (Pdgfra-CreERTM :: Rosa26YFP) mice 14 days 
post tamoxifen and immunolabelled to detect OPCs (PDGFRa, red), YFP (green) and 
oligodendrocyte lineage cells (OLIG2, blue).  Representative images from the cortex (a) and 
corpus callosum (b) showing colocalization between YFP+ cells and OLIG2+ cells (white 
arrowheads, oligodendrocytes) and YFP+, OLIG2+ and PDGFRa+ cells (yellow arrow heads, 
OPCs).  (c) graphical representation showing proportion (%) of YFP+ cells that also express 
OLIG2 in the corpus callosum and cortex of control and Lrp1-deleted mice (mean ± SEM, ). 




To determine whether LRP1 influences oligodendrogenesis, we next determined the 
proportion of YFP+ cells that were PDGFRα-negative OLIG2+ newborn OLs in the corpus 
callosum (Fig. 20a-f) or motor cortex (Fig. 20g-l) of P57+7, P57+14, P57+30 and P57+45 control 
and Lrp1-deleted mice.  At P57+7 and P57+14, oligodendrogenesis was equivalent in the 
corpus callosum of control and Lrp1-deleted mice, however by P57+30, a larger proportion of 
YFP+ cells had become newborn OLs in the corpus callosum of Lrp1-deleted mice, and this 
effect was sustained at P57+45 (Fig. 20m).  Similarly, for the first two weeks, OL production 
was equivalent for OPCs in the motor cortex of control and Lrp1-deleted mice, however, by 
P57+30, the proportion of YFP+ cells that were newborn OLs was higher in the motor cortex 
of Lrp1-deleted mice relative to controls (Fig. 20n).  At P57+30, we also performed cell density 
measurements and found that new oligodendrocyte density was also significantly increased 
in the corpus callosum (control 107.2 ± 14.9 cell/mm2 Lrp1-del 161.8 ± 27.4 cell/mm2; avg ± 
SD, n= >4 mice per genotype; t-test,  p= 0.001) and motor cortex (control 42.55 ± 9.2 cell/mm2 
Lrp1-del 61.34 ± 7.0cell/mm2; avg ± SD, n= >4 mice per genotype; t-test;  p= 0.01) of Lrp1-
deleted mice compared to controls at P57+30 (data not shown).  These results suggest that in 
the healthy adult mouse brain CNS, LRP1 is a negative regulator of OPC differentiation.  
 
4.2.4 LRP1 reduces the generation of mature, myelinating oligodendrocytes  
 
As OPCs differentiate, they rapidly downregulate their expression of PDGFRα, the NG2 
proteoglycan and voltage-gated sodium channels (NaV) (Richardson et al., 1988; Pringle et al., 
1989; De Biase et al., 2010; Kukley et al., 2010; Clarke et al., 2012), and become highly ramified 
pre-myelinating OLs, that either die or continue to mature into myelinating OLs, that are 
characterised by the elaboration of myelin internodes (Trapp et al., 1997; Psachoulia et al., 
2009; Hughes et al., 2013; Young et al., 2013; Tripathi et al., 2017).  In order to determine 
Figure 20: LRP1 suppresses adult oligodendrogenesis in the adult mouse corpus callosum 
and motor cortex 
Immunohistochemical analysis of coronal brain sections from P57+7 (a, d) P57+14 (b, e) and 
P57+30 (c, f) control (Pdgfra-CreERTM :: Rosa26-YFP) and Lrp1-deleted (Pdgfra-CreERTM :: 
Rosa26-YFP :: Lrp1fl/fll) mice to detect PDGFRa (red) and YFP (green) in the corpus callosum 
(CC).  Yellow arrows indicate YFP+, PDGFRa+ OPCs and white arrows indicate the newborn 
YFP+, PDGFRa-neg oligodendrocytes they produce during the tracing period.  (m) Graphical 
representation of the proportion (%) of YFP+ cells in the corpus callosum of 7,14,30 and 45 
days post tamoxifen in control and Lrp1 deleted mice that are YFP+ PDGFRα-neg OLIG2+ 
newborn oligodendrocytes (mean ± SEM, n=4-6 mice per genotype per timepoint; [2-way 
ANOVA genotype F (1,28)=22.3,p = <0.0001; Time F (3,28) =109.7, p = <0.0001; interaction 
F(3, 28)= 1.902, p = 0.15] with Bonferroni multiple comparisons; 30 days p= 0.004, 45 days p= 
0.006).  Coronal brain sections were taken from Pdgfra-CreERTM :: Rosa26-YFP (control)  and 
Pdgfra-CreERTM :: Rosa26-YFP :: Lrp1fl/fl (Lrp1fl/fl) mice and immunolabelled to detect PDGFRa 
(red) and YFP (green) at 7 (g,j) 14 (h,k) and 30 days (i,l) post tamoxifen.  Yellow arrows indicate 
OPCs (YFP+, PDGFRa+ cells) and white arrows indicate newly formed oligodendrocytes (YFP+, 
PDGFRa-neg). (n) graphical representation depicting the proportion of newly formed 
oligodendrocytes over total YFP+ cells at 7, 14, 30 and 45 days post tamoxifen (mean ± SEM); 
[2-way ANOVA genotype F (1,26)=22.5, p = <0.0001; Time F (3,26) =23.4, p = <0.0001; 
interaction F(3, 26)= 4.56, p = 0.011] with Bonferroni multiple comparisons; 30 days p= 
<0.0001 and 45 days p= 0.027). The nuclear marker Hoescht 33342 was used to label cell 
nuclei (blue).  Scale bars = 17µm (a-f) and 34µm (g-l). CC = corpus callosum, Ctx= cortex  
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whether Lrp1-deletion increases the number of myelinating OLs, we fluorescently labelled a 
subset of OPCs in the adult mouse brain with a membrane-targeted from of green fluorescent 
protein (GFP), allowing us to visualise the full morphology of the OPCs and the OLs they 
produce.  We have previously shown that tamoxifen delivery to adult Pdgfrα-CreERTM :: Tau-
GFP mice does not result in the specific fluorescent labelling of OPCs and their progeny 
(Pitman et al., 2019).  Therefore, for this study, we instead delivered tamoxifen to adult LE-
control (Pdgfrα-CreERT2 :: Tau-GFP) and LE-Lrp1-deleted (Pdgfrα-CreERT2 :: Tau-GFP :: Lrp1fl/fl) 
transgenic mice.  The Pdgfrα-CreERT2 transgenic mouse (Rivers et al., 2008) has a lower 
recombination efficiency (LE) than the Pdgfrα-CreERTM transgenic mouse (Kang et al., 2010), 
so we first evaluated the efficiency of Lrp1 deletion using this mouse model.  Coronal brain 
cryosections from P57+30 LE-control and LE-Lrp1-deleted mice were immunolabelled to 
detect PDGFRα (green) and LRP1 (red) (Fig. 21 a, b), and while 100% of PDGFRα+ OPCs 
expressed LRP1 in the motor cortex of LE-control mice, only 35% ± 9% of PDGFRα+ OPCs in the 
motor cortex expressed LRP1 in the LE-Lrp1-deleted mice with similar results in the corpus 
callosum (100% ± 0% for LE-control 37% ± 7 for LE-Lrp1-deleted mice) (Fig. 21c).   
While only ~65% of OPCs lacked LRP1 in the LE-Lrp1-deleted mice, this was sufficient to 
increase adult oligodendrogenesis beyond that of LE-control mice.  Brain cryosections from 
P57+30 LE-control and LE-Lrp1-deleted mice were immunolabelling to detect GFP (green), 
PDGFRa (red) and OLIG2 (blue) (Fig. 21d, e), and we found that the proportion of GFP+ cells 
have become PDGFRa-negative, OLIG2+ newborn OLs in the motor cortex was significantly 
elevated [(p= 0.03, n= 4 mice per genotype, t-test)] in the LE-Lrp1-deleted mice (56.3% ± 
2.06%) compared to controls (49.2% ± 1.51).  Furthermore, by examining the morphology of 
newborn GFP+ OLs in LE-control (Fig. 21g) and LE-Lrp1-deleted mice (Fig. 21h), we determined 
that Lrp1-deletion was associated with the generation of more myelinating OLs (Fig. 21f), 
Figure 21: Lrp1-deletion increases the number of mature, myelinating oligodendrocytes 
added to the motor cortex of adult mice  
Confocal image of the corpus callosum (CC) of P57+30 low efficiency control (a, LE-Pdgfr -
CreERT2) and low efficiency Lrp1 deleted (b,LE-Pdgfra-CreERT2 :: Lrp1fl/lf) mice immunolabelled 
to detect OPCs (PDGFRa, green), LRP1 (red) and Hoescht 33342 (blue). (c) Graphical 
representation of the proportion of PDGFRα+ OPCs that express LRP1 in the CC of LE-control 
and the LE-Lrp1-del mice (mean ± SD, n= 3 mice per group; unpaired t-test, *** p =0.0008).  
(d) Confocal image from the motor cortex (Ctx) of a P57+30 control (LE-Pdgfrα-CreERT2 :: Tau-
mGFP) mouse immunolabelled to detect PDGFRα (red) and GFP (green). Yellow arrow heads 
indicate GFP-labelled OPCs.  (e)  Confocal image from the Ctx of a P57+30 control (LE-Pdgfrα-
CreERT2 :: Tau-mGFP) mouse immunolabelled to detect PDGFRα (red) and GFP (green) 
showing the two distinct morphologies of premyelinating (arrowhead) and mature (arrow), 
myelinating oligodendrocytes (arrow).  (f) Quantification of the proportion (%) of GFP+ cells 
that are PDGFRα+ OLIG2+ OPCs, PDGFRα-neg OLIG2+ premyelinating oligodendrocytes and 
PDGFRα-neg OLIG2+ mature, myelinating oligodendrocytes (mean ± SEM, n = 4 mice per 
genotype; [2-way ANOVA cell stage F (2,18)=193.3, p = <0.0001; genotype F (1,18) = 2.008e-
005, p = 1; interaction F(2, 18)= 17.9, p <0.0001] with Bonferroni multiple comparisons, * p = 
0.024 and *** p = 0.004).  Confocal image of GFP+ myelinating oligodendrocytes in the Ctx of 
P57+30 control (g, g’) and LE-Lrp1-deleted (h, h’) mice.  (i) The number of internodes 
elaborated by individual GFP+ myelinating oligodendrocytes in control and LE-Lrp1-deleted 
mice (mean ± SEM, n= 10-12 oligodendrocytes from n=3 mice per genotype; unpaired t-test, 
p= 0.3).  (j) The average length of internodes elaborated by individual GFP+ myelinating 
oligodendrocyte in control and LE-Lrp1-deleted mice (n=10-12 OL oligodendrocytes from 3 
mice per genotype; unpaired t-test, p= 0.6 respectively).  (k)  Internode length distribution for 
GFP+ internodes measured in the Ctx of P57+30 control and LE-Lrp1-deleted mice (n= 519 
control and n= 408 LE-Lrp1fl/fl GFP+ internodes measured; K-S test, D= 0.053, p= 0.5).  Scale 
























while the proportion of YFP+,PDGFRa-negative cells that are mature OLs was unchanged 
between control and Lrp1-deleted mice.  Detailed morphological analysis of individual GFP+ 
myelinating OLs in the motor cortex of LE-control and LE-Lrp1-deleted mice revealed that the 
myelinating profile of OLs was not affected by Lrp1 deletion.  The average number of 
internodes elaborated by GFP+ myelinating OLs (Fig. 21i) or the mean length of internodes 
elaborated by GFP+ myelinating OLs (Fig. 21j) was equivalent in LE-control and LE-Lrp1-deleted 
mice.  Additionally, the length distribution for internodes elaborated by GFP+ myelinating OLs 
was also the same in the motor cortex of LE-control and LE-Lrp1-deleted mice (Fig. 21k).  These 
data indicate that in the healthy adult mouse brain, LRP1 negatively regulates the number of 
myelinating OLs produces from OPCs, but does not influence internode elaboration or 
maintenance by the resulting cells.    
 
4.2.5 LRP1 does not influence NaV, AMPA receptor, L- or T-Type VGCC, PDGFRα or LRP2 
expression by OPCs 
 
LRP1 could influence a number of signaling pathways known to directly or indirectly regulate 
OPC proliferation and / or the number of newborn OLs present in the brain.  The conditional 
deletion of Lrp1 from neurons in vitro and in vivo has been shown to increase AMPA receptor 
turnover and reduce expression of the GluA1 subunit of the AMPA receptor (Gan et al., 2014).  
Adult OPCs express AMPA receptors (Gallo et al., 1996; Gudz, 2006; Zonouzi et al., 2011) and 
glutamatergic signalling has been shown to influence OPC proliferation and differentiation 
(Gallo et al., 1996; Fannon et al., 2015), as well as migration (Gudz, 2006), and,  AMPA receptor 
signalling has been shown to enhance the survival of premyelinating oligodendrocytes during 
development (Kougioumtzidou et al., 2017).  To determine whether LRP1 regulates AMPA 
receptor signalling in OPCs, we obtained whole cell patch clamp recordings from GFP-labelled 
OPCs in the motor cortex of P57+30 control (Lrp1fl/fl :: Pdgfrα-histGFP) and Lrp1-deleted 
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(Pdgfrα-CreERTM :: Lrp1fl/fl :: Pdgfrα-histGFP) mice (Fig. 22).  OPCs elicit a large inward voltage-
gated (sodium) current in response to a series of voltage-steps (Fig. 22a), and the INa amplitude 
was not affected by genotype (Fig. 22b).  The resting membrane potential (Fig. 22c) and the 
capacitance (size; Fig. 22d) of OPCs was also unaffected by LRP1 expression.  AMPA receptors 
were next activated by the bath application of 100µm kainate, which evoked a large and 
sustained inward current in control and Lrp1-deleted OPCs (Fig. 22e), and the amplitude of 
the evoked current was found to be equivalent for control and Lrp1-deleted OPCs across all 
voltages examined (Fig. 22f).  These data indicate that Lrp1-deletion is unlikely to affect the 
composition or cell-surface expression of AMPA/kainate receptors in OPC in the healthy adult 
mouse brain.     
LRP1 has also been shown to regulate the cell surface expression and distribution of N-Type 
voltage gated calcium channels (VGCC), by interacting with the a2d subunit (Kadurin et al., 
2017).  In adult OPCs, the closely related L-Type VGCCs have been shown to reduce OPC 
proliferation in the motor cortex and corpus callosum (Pitman et al., 2019), and influence the 
maturation of OPCs into OLs in vitro (Cheli et al., 2015). OPCs also express the T-Type VGCC,  
commonly referred to as the low voltage activated Ca++ channel  (Williamson et al., 1997; 
Fulton et al., 2010).   To determine whether the distribution of L-Type or T-Type VGCCs in OPCs 
is altered following Lrp1 deletion, we performed whole cell patch clamp electrophysiology and 
measured the current density (pA/pF)  in control and Lrp1-deleted mice (Fig. 22g).  We found 
that the L and T-Type VGCC current densities were equivalent for OPCs in the motor cortex of 
control and Lrp1-deleted mice (Fig. 22h), indicating that LRP1 does not influence L-Type or T-
Type VGCC expression in adult OPCs.  
LRP1 has also been shown to influence the cell surface expression of PDGFRβ (Takayama et 
al., 2005; Muratoglu et al., 2010), a receptor closely related to PDGFRa, an important 
Figure 22: LRP1 does not alter NaV, VGCC, AMPA/kainate or PDGFRa receptor expression 
in OPCs 
Control (Pdgfra-histGFP :: Lrp1fl/fl) and Lrp1-deleted (Pdgfra-CreERTM :: Pdgfra-histGFP :: 
Lrp1fl/fl) mice were gavaged at P57 and were sacrificed at P57+30 for electrophysiological 
analysis.  GFP+ cells in the motor cortex were whole-cell patch clamped and determined to be 
OPCs by the presence of a sodium spike greater than 100mv  (a) Representative traces of 
voltage-gated sodium channels currents evoked in GFP+ OPCs from control and Lrp1-deleted 
mice. Graphical representation showing no change in peak inward sodium current (b, 
unpaired t-test, n = 8-9 cells across n= 3 animals per genotype, p= 0.8) and cell capacitance 
(c, unpaired t-test, n = 9-11 cells across n= 3 animals per genotype, p= 0.9). (d) Representative 
trace showing the leak subtracted L-type calcium current evoked in response to a depolarising 
step. (e) Graphical representation showing the current density-voltage relationship for leak 
subtracted L-Type VGGC currents recorded from controls (dark circles, n= 7 cells across n=3 
mice)  and Lrp1 deleted (grey squares, n=11 cells across n=3 mice) (mean±SEM, [2-way 
ANOVA; Interaction F(10,176)=0.62, p=0.8; genotype F=(1,176)=1.03), p=0.3; voltage 
F(10,176)=66.8, p=<0.0001]).  Graphical representation showing the current density-voltage 
relationship for leak subtracted T-Type VGGC currents recorded from control (dark circles, n= 
11 cells across n=3 mice)  and Lrp1 deleted (grey squares, n=10 cells across n=3 mice) 
(mean±SEM, [2-way ANOVA; Interaction F(9,190)=1.14, p=0.3; genotype F=(1,190)=2.85), 
p=0.09; voltage F(9,190)=23.5, p= <0.0001]). (g) Example traces from control and Lrp1-del 
OPCs in response to bath application of 100µM kainate (h)  Graphical representation showing 
the current voltage relationship of AMPA/kainate receptors in control (n= 3 cells) and Lrp1-
deleted (n=3 cells) mice following bath application of kainate (mean±SEM; [2-way ANOVA; 
Interaction F(6,28)=0.25, p=0.9; genotype F=(1,28)=0.91), p=0.3; voltage F6,28)=31.3, 
p=<0.0001]). Coronal brain sections from control and Lrp1 deleted mice at P57+30 were 
immunolabelled to detect OPCs (PDGFRa). Representative confocal images from control (i) 
and Lrp1-deleted (j) mice showing typical PDGFRa expression in OPCs. (e) graphical 
representation showing the mean grey value of PDGFRa expression between control and 
Lrp1-deleted OPCs (mean± SD; n= a minimum of 24 cells across 3 animals per genotype; 












mitogenic receptor regulating OPC proliferation, survival and migration (Noble et al., 1988; 
Richardson et al., 1988; Pringle et al., 1989).  To determine whether LRP1 is a negative 
regulator of PDGFRa expression, we performed immunohistochemistry to detect PDGFRa 
expression in the motor cortex of P57+30 control and Lrp1-deleted mice (Fig. 22i-j) and 
measured the mean grey value (Fig. 22k) and the maximum intensity for PDGFRa expression 
by OPCs (Fig. 22l), to determine that LRP1 did not influence PDGFRα expression.  
The low-density lipoprotein receptor related protein 2 (LRP2) is a large cell surface receptor 
that is closely related to LRP1, with a number of common ligands (Spuch et al., 2012).  It is 
unclear whether cells of the oligodendrocyte lineage express LRP2 (Cahoy et al., 2008; Zhang 
et al., 2014; Hrvatin et al., 2018), or whether Lrp1-deletion could alter Lrp2 expression, 
however, LRP2 can increase the proliferation of neural precursor cells in the subependymal 
zone (Gajera et al., 2010), and the proliferation and survival of skin cancer cells (Andersen et 
al., 2015).  By performing immunohistochemistry to detect LRP2 and PDGFRα or ASPA in 
coronal brain cryosections from P57+30 control and Lrp1-deleted mice, we determined that 
LRP2 is not expressed by OPCs or OLs in mice of either genotype (Fig. 23a-d).  However, LRP2 
was highly expressed by Iba1+ microglia (Fig. 23e). These data indicate that LRP2 is not 
responsible for the elevated OPC proliferation and differentiation observed in Lrp1-deleted 
mice.    
 
4.2.6 LRP1 ligand-mediated activation and Lrp1-deletion do not alter OPC proliferation in vitro 
 
Our data suggest that in the healthy adult mouse CNS, Lrp1-deletion either increases OPC 
proliferation which then results in an increase in the number of newborn OLs added to the 
brain over time, or increases OPC differentiation, which subsequently triggers a homeostatic 








Figure 23: LRP2 is not expressed by wild type or Lrp1-deleted oligodendrocyte lineage cells  
Brain sections from control (Pdgfra-CreERTM) and Pdgfra-CreERTM :: Lrp1fl/fl at P57+30 were 
taken and immunolabelled to detect OPCs (PDGFRa, red) and LRP2 (green) in the corpus 
corpus callosum (a,b). Brain sections from control (Pdgfra-CreERTM) and Pdgfra-CreERTM :: 
Lrp1fl/fl at P57+30 were taken and immunolabelled to detect oligodendrocytes (ASPA, red) 
and LRP2 (green) in the cortex (c,d). (e) brain sections from control (Pdgfra-CreERTM) mice 
were taken and immunolabelled to detect microglia (IBA1, green) and LRP2 (red)  White 
















that Lrp1 deletion could enhance the proliferation of retinal endothelial cells (Mao et al., 
2016), while the activation of LRP1 by its ligand tissue plasminogen activator (tPa), could 
enhance the proliferation of interstitial fibroblasts (Lin et al., 2010).  To determine whether 
LRP1 directly suppresses OPC proliferation, we generated primary OPC cultures from the 
cortex of P0-P5 control (Pdgfra-hGFP) or Lrp1-deleted (Pdgfra-hGFP :: Lrp1fl/fl) mice.  At ~7DIV, 
OPCs were incubated with 1µM TAT-Cre for 90 min, and LRP1 expression was determined 2 
days later by performing immunocytochemistry to detect PDGFRa (red), GFP (green) and LRP1 
(blue) (Fig. 24a, b).  All OPCs cultured from control mice expressed LRP1 (100% ± 0%), while 
only 21% ± 4% of PDGFRα+ OPCs cultured from Lrp1-deleted mice retained LRP1 expression 
following TAT-Cre treatment (Fig. 24 c; t-test, p<0.0001).  At this same time-point, equivalent 
control and Lrp1-deleted OPC cultures were also exposed to EdU, to label all cells that enter 
s-phase of the cell cycle over a 10-hour period.  By performing immunocytochemistry to detect 
GFP (green), LRP1 (red) and EdU (Fig. 24d, e), we found that the level of LRP1 expression did 
not influence OPC proliferation, as the fraction of PDGFRa+ OPCs that were EdU+ was 
equivalent in control and Lrp1-deleted cultures (Fig. 24f).  
To further confirm that LRP1 activation by ligands does not directly influence OPC 
proliferation, we added the LRP1 ligands tPa (20nM) or activated alpha-2 macroglobulin 
(*a2M; 60mM), or vehicle (milliQ water) to OPC primary cultures for 10 hours, along with EdU 
(Fig. 24).  We evaluated OPC proliferation by performing immunocytochemistry to detect 
(PDGFRa, green) and EdU (red) (Fig. 24g, h, j) and found that the proportion of EdU+ OPCs did 
not change with the addition of tPa or *a2M compared to vehicle treated controls  (Fig 24j), 
indicating that LRP1 activation by these ligands is also unable to modify OPC proliferation in 




Figure 24: Lrp1 deletion and activation do not effect OPC proliferation in vitro 
Purified OPCs from control (a, Pdgfra-histGFP) and Lrp1-deleted (b, Pdgfra-histGFP :: Lrp1fl/fl 
) mice were treated with 1µM TAT-Cre for 90 minutes then left for 48 hours then 
immunolabelled with PDGFRa (red), LRP1 (blue) and GFP (green). (c) graphical representation 
comparing the percentage of LRP1+ OPCs 48 hours post TAT-Cre (mean ± SEM, n= 3 
independent cultures for control and n= 4 independent cultures for Lrp1-deleted mice, 
unpaired t-test, p= <0.0001). Purified primary OPCs from control (d, Pdgfra-histGFP) and Lrp1 
deleted (e, Pdgfra-histGFP :: Lrp1fl/fl)  were treated with EdU for 10 hours then 
immunolabelled to detect GFP (green), LRP1 (red) and EdU (blue). (f) Graphical representation 
comparing the % of EdU+ GFP+ cells following TAT-Cre treatment (mean± SEM, n= 5-6 
independent cultures, unpaired t-test p= 0.3). Example images from primary OPCs 
immunolabelled to detect PDGFRa (green) and EdU (red) following 10 hours of EdU exposure 
in combination with vehicle (g) 20nM tPa (h) or 60 nM *a2M (j).  Graphical representation 
comparing the % of EdU+, PDGFRa+ cells between vehicle and tPa treated cells (i, unpaired t-
test, n= 4 independent cultures, p=0.2) or *a2M treated (k, unpaired t-test, n= 4 independent 
cultures p=0.8).  Scalebar represents 17µm, DIV = Days in vitro, tPA = tissue plasminogen 
activator, *a2M = activated alpha-2 macroglobulin. The nuclear marker Hoescht 33342 was 












4.2.7 Lrp1-deletion but not LRP1 ligand-mediated activation influences OPC differentiation in 
vitro  
 
In vitro, OPCs can be triggered to differentiate by withdrawing the mitogen PDGF-AA and 
providing triiodothyronine (T3) in the culture medium.  To determine whether Lrp1 deletion 
can enhance OPC differentiation, Tat-Cre-treated control and Lrp1-deleted cultures were 
transferred into differentiation medium for 4 days before they were immuno-labelled to 
detect PDGFRa OPCs (red) and MBP+ OLs (green) (Fig. 25a, b).  The proportion of cells that 
were PDGFRα+ OPCs was reduced in the Lrp1-deleted, and the number of cells that were MBP+ 
OLs was significantly increased compared with control cultures (Fig. 25c). 
To determine whether ligand activation of the LRP1 receptor was sufficient to suppress OPC 
differentiation, OPC primary cultures were instead transferred into differentiation medium 
containing vehicle, tPA (20nM) or *a2M (60nM) for 4 days.  By performing 
immunocytochemistry to detect PDGFRa+ OPCs and MBP+ OLs (Fig. 25d-f) we found that the 
activation of LRP1 by tPA or *a2M had no impact on the proportion of cells that differentiated 
over time (Fig. 25g).  These data suggest that LRP1 normally acts to suppress OPC proliferation, 
however, this effect is independent of tPA and a2M signalling.  Furthermore, the effect of 
LRP1 on OPCs proliferation is likely to be a secondary consequence of its ability to regulate 
OPC differentiation.    
 
4.2.8 OPC specific Lrp1 deletion in the cuprizone mouse model of demyelination results in 
reduced lesion volume 
   
Having shown that Lrp1 deletion increases OPC differentiation and consequently new OL 
addition, we wanted to determine whether the deletion of Lrp1 from OPCs could improve 
remyelination.  Control (Pdgfrα-CreERTM :: Rosa26-YFP) and Lrp1-deleted (PdgfrαCreERTM :: 
Rosa26-YFP :: Lrp1fl/fl) mice received tamoxifen by oral gavage at P57, and were transferred 
 
 
Figure 25: LRP1 expression reduces the OPC differentiation in vitro  
Purified OPCs isolated from Lrp1+/+(a) or Lrp1fl/fl (b) mice were treated with TAT-Cre then left 
for 48 hours before being exposed to differentiation media for 4 days. The cells were then 
immunostained to detect PDGFRa (red) and MBP (green) (c) graphical representation 
comparing the percentage of PDGFRa+ or MBP+ cells in control and Lrp1fl/fl cultures (mean ±  
SEM, n= 3 independent cultures; [2-way ANOVA cell type F (1,8)=395,p= <0.0001; interaction 
(F(1,8) = 37.7,p= 0.0003; genotype (F1,8) =0.0, p= 1] with Sidak’s multiple comparisons test.  
OPCs from control (Lrp1+/+) mice were exposed to differentiation media containing vehicle 
(d), tPa (e) or *a2M (f) for 4 days then immunostained to detect PDGFRa and MBP. (g) 
Graphical representation showing the percentage of PDGFRa+ or MBP+ cells after 4 days in 
differentiation medium (mean ±  SEM, n= 3 independent cultures; [2-way ANOVA cell type F 
(1,10)=31.4, p= 0.0002; interaction (F (2,10) = 0.028, p= 0.9; genotype F(2,10) =2.0410-0.12, p= 
1]) . tPa = tissue plasminogen activator, *a2M = activated alpha 2 macroglobulin   The nuclear 















onto a diet containing 0.2% (w/w) cuprizone at P64.  After 5 weeks, mice were perfusion fixed 
and coronal brain sections stained to detect myelin (black-gold staining; Fig. 26), revealing 
overt demyelination in the corpus callosum of control and Lrp1-deleted mice (Fig. 26a-d).  By 
quantifying the proportion of the corpus callosum with overt demyelination, we determined 
that Lrp1-deleted mice had less demyelination than controls (Fig. 26e)  
Cuprizone initially causes OL death, yet oligodendrogenesis occurs during cuprizone delivery. 
When mice received EdU via their drinking water during weeks 2-5 of cuprizone feed, we 
found that the vast majority of OLIG2+ cells were EdU+ in control (146 of 154 cells counted) 
and Lrp1-deleted mice (97 of 106 cells counted) (Fig 27).  Elucidating the role of LRP1 in myelin 
repair in the corpus callosum is complicated by the shared contribution of parenchymal OPCs 
and neural stem cell-derived OPCs to OL generation and remyelination (Xing et al., 2014).  
Indeed, when we perform immunohistochemistry to detect YFP-labelled cells (green), the OPC 
marker PDGFRa (red) and the oligodendrocyte lineage marker OLIG2 (blue), in coronal 
cryosections from control and Lrp1-deleted mice, we find large numbers of OPCs (PDGFRα+ 
OLIG2+ cells) and OLs (PDGFRα-neg OLIG2+ cells) that are YFP-negative (Fig. 26 f,g), indicating 
that these cells were not derived from the YFP+ parenchymal OPC population, but instead 
likely originate from neural stem cells in the subventricular zone (SVZ). The YFP+ parenchymal 
OPCs lacked LRP1 (Fig. 28b 124 of 124 cells counted), however, the YFP-negative neural stem 
cell-derived OPCs had intact LRP1 expression (42 of 42 cells counted).  We found no difference 
in the proportion of recombined parenchymal OPCs within the corpus callosum between 
control and Lrp1-delted mice (Fig 26j;  t-test, p= 0.4, n= > 3 mice per genotype).  Furthermore, 
60% ± 15% of YFP+ cells were PDGFRa-negative, OLIG2+ newly generated OLs in control mice, 
and 65% ± 5% of YFP+ cells were PDGFRa-negative, OLIG2+ newly generated OLs in the Lrp1-
deleted mice (Fig. 26k; unpaired t-test, p= 0.8, n=>3 mice per genotype).  As the total density 
of OLIG2+ PDGFRa-negative OLs present in the corpus callosum of control and Lrp1-deleted 
 
Figure 26: Cuprizone induced lesion size is reduced in mice lacking LRP1 despite no change 
in new oligodendrocyte addition  
Control (Pdgfra-CreERTM :: Rosa26YFP) and Lrp1-deleted (Pdgfra-CreERTM :: Rosa26YFP :: 
Lrp1fl/fl) mice were fed a diet containing 0.2% cuprizone for 5 weeks. At the end of 5 weeks, 
brain sections were collected and stained with Black Gold to detect myelin. Examples of 
corpus callosal demyelination in control (a,b) and Lrp1-deleted (c,d) mice. (e) graphical 
representation showing the percentage of demyelination in the corpus callosum between the 
dotted white lines (mean±SD; n= minimum of 4 mice per genotype; unpaired-t- test with 
Welch’s correction, p= 0.04). Control (f) and Lrp1-deleted (g) coronal brain sections 
immunolabelled to detect YFP (green), PDGFRa (red) and OLIG2 (blue). White dashed line 
indicates the boundary of the corpus callosum. (f) representative confocal image from the 
corpus callosum of cuprizone treated control (h) and Lrp1-deleted (i) mice immunolabelled 
to detect OPCs (PDGFRa, red), YFP (green) and OLIG2 (blue). (j) graphical representation 
showing the percentage of YFP+, PDGFRa+ over total PDGFRa+ cells after 5 weeks of cuprizone 
(mean± SD; n= minimum of 3 mice per genotype; unpaired t-test, p=0.4) (k) graphical 
representation showing the percentage of newly formed oligodendrocytes over total YFP+ 
cells in GFP+ regions after 5 weeks of cuprizone (mean± SD; n= minimum of 3 mice per 
genotype; unpaired t-test, p=0.9). (g)  graphical representation showing the density of 
oligodendrocytes in the corpus callosum after 5 weeks of cuprizone (mean± SD; n=minimum 
of 4 mice per genotype; unpaired t-test, p=0.8). Scale bar represents 150µm (a,c) 100µm (f,g) 
and 17µm (h,i). Regions of demyelination outlined by red dashed line. White arrow indicate 
PDGFRa+ cells that don’t express YFP, yellow arrowheads indicate PDGFRa+ cells that also 








Figure 27: The vast majority of OLIG2 labelled cells are EdU+ 
Control (Pdgfra-CreERTM) and Lrp1-deleted (Pdgfra-CreERTM :: Lrp1fl/fl) mice were fed a diet 
containing 0.2% cuprizone for 5 weeks and administered EdU for the 3 finals weeks. Low (a) 
and high (b,b’) magnification images from the corpus callosum of control mice 
immunolabelled to detect OLIG2 (blue) and EdU (red). Low (c) and high (d,d’) magnification 
images from the corpus callosum of control mice immunolabelled to detect OLIG2 (blue) and 
EdU (red). Scale bar represents 34µm for a,c and 20µm for b and d. White arrowheads 
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Figure 28:  SVZ derived OPCs express LRP1 following cuprizone administration  
Control (Pdgfra-CreERTM :: Rosa26YFP) and Lrp1-deleted (Pdgfra-CreERTM :: Rosa26YFP :: 
Lrp1fl/fl) mice were fed a diet containing 0.2% cuprizone for 5 weeks. Representative images 
of the corpus callosum from control (a) and Lrp1-deleted (b) mice immunostained to detect 
OPCs (PDGFRa, red), YFP (green) and LRP1 (blue). Yellow arrowheads indicate PDGFRa+,YFP+  
,LRP1+ cells, white arrowheads indicate PDGFRa+, YFP-negative, LRP1+ cells, yellow arrows 
indicate PDGFRa+, YFP+, LRP1-negative cells and white arrows indicate PDGFRa-negative, 





mice was also equivalent (Fig. 26l, t-test genotype, p=0.8, n=>4 mice per genotype) total OL 
production from parenchymal and stem cell-derived OPCs was equivalent in control and Lrp1 
deleted mice on a cuprizone diet.  
These data suggest that LRP1 does not influence OPC differentiation in the same way in the 
healthy and injured CNS.  Within the demyelinated environment, parenchymal OPCs lacking 
Lrp1 appear to produce the same number of new OLs as those with intact LRP1, but the 
resulting OLs are less able to remyelinate the lesion site.   
4.3 Discussion  
 
Understanding the signalling pathways that regulate OPC and OL function is critical to 
improving myelin repair outcomes.  LRP1 is highly expressed in OPCs, and while its function is 
yet to be fully elucidated, LRP1 expression is rapidly downregulated as OPCs differentiate into 
OLs (Cahoy et al., 2008; Zhang et al., 2014; Auderset et al., 2016a).  In other cell types, LRP1 
signals in a variety of different ways (Lillis et al., 2008; Auderset et al., 2016b; Bres and 
Faissner, 2019), regulating cellular functions including proliferation, differentiation (Boucher 
et al., 2007; Mao et al., 2016; Safina et al., 2016) and migration (Mantuano et al., 2010; 
Barcelona et al., 2013; Mantuano et al., 2015; Ferrer et al., 2016; Sayre and Kokovay, 2019).  
To examine the importance of LRP1 signalling for adult OPC function, we conditionally deleted 
Lrp1 from essentially all OPCs in the adult mouse brain and examined the effect that Lrp1-
deletion had on OPC proliferation, oligodendrogenesis, and adult myelination.  We found that 
in the healthy CNS, Lrp1 deletion led to a significant increase in the generation of new-born 
OLs with no impact on OL morphology.  However, following demyelination, LRP1 no longer 
influenced the number of new OLs produced by OPCs, but instead influenced the capacity of 
the resulting OLs to remyelinate.   
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4.3.1 Why does Lrp1-deletion have a delayed effect on OPC proliferation in the healthy adult 
CNS? 
 
In the healthy adult mouse CNS, most OPCs are in G0 at any given time (Psachoulia et al., 2009).  
OPCs in the corpus callosum re-enter the cell cycle to divide once every ~10 days, while those 
in the cortex divide once every ~38 days (Young et al., 2013).  We found that Lrp1-deletion did 
not immediately alter the proportion of OPCs in S-phase of the cell cycle, as the proportion of 
OPCs that became EdU labelled over time was equivalent between control and Lrp1-deleted 
mice in the corpus callosum and cortex.  However, when EdU was instead delivered 32 days 
after Lrp1 deletion, we found that more OPCs in the corpus callosum were in S-phase of the 
cell cycle in Lrp1-deleted mice compared with controls.  LRP1 has been shown to influence the 
proliferation of other cell types (Boucher et al., 2007; Basford et al., 2009; Mao et al., 2016; 
Safina et al., 2016; Yang et al., 2018; Zucker et al., 2019), negatively influencing the hypoxia-
induced proliferation of mouse and human retinal endothelial cells, by regulating the activity 
of poly (ADP-ribose) polymerase-1 (PARP-1) (Mao et al., 2016), and suppressing the 
proliferation of mouse vascular smooth muscle cells in vivo, by reducing PDGFRb activity 
(Boucher et al., 2003; Basford et al., 2009).  OPCs do not express PDGFRb, and while they do 
express the closely related mitogenic cell surface receptor PDGFRa (Asakura et al., 1997), we 
found that PDGFRa expression by OPCs was not altered following Lrp1-deletion, indicating 
that LRP1 does not suppress OPC proliferation by influencing PDGFRa expression.   
As Lrp1-deletion does not acutely influence OPC proliferation in vivo, the effect of LRP1 on 
OPC proliferation may be indirect.  Indeed, deleting Lrp1 from early postnatal OPCs in vitro 
does not alter their proliferation (EdU-incorporation), nor does exposure to the LRP1 ligands 
tPA or *α2M.  Lrp1-deletion also failed to alter the proliferation of OPCs isolated from early 
postnatal Olig-2Cre :: Lrp1fl/fl mice (Lin et al., 2017).  LRP1 could indirectly influence OPC 
proliferation by modulating the endocytosis, degradation and recycling of cell surface proteins 
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and their ligands (Takayama et al., 2005; Parkyn et al., 2008; Liu et al., 2010; Muratoglu et al., 
2010; Capurro et al., 2012; Farfán et al., 2013; Maier et al., 2013; Mantuano et al., 2013b; 
Kadurin et al., 2017; Wujak et al., 2018; Schubert et al., 2019).  For example, LRP1 can regulate 
VGCC receptor function and distribution in a human kidney cell line (Kadurin et al., 2017), and 
the targeted deletion of Cacna1c (L-Type VGCC), using Pdgfra-CreERTM :: Cacna1c fl/fl mice, 
increases OPC proliferation in the adult mouse corpus callosum and motor cortex (Pitman et 
al., 2019).  Therefore, we hypothesised that Lrp1-deletion could alter the trafficking of VGCCs 
to ultimately influence OPC proliferation, however, we found no evidence that LRP1 regulated 
VGCC function or distribution in OPCs.  The influence of Lrp1-deletion on OPC proliferation 
could alternatively result from compensation from another LDL receptor family member.  
Notably, LRP2 has been linked to the enhanced survival and proliferation of melanoma cells 
(Andersen et al., 2015) as well as an increased risk of relapses in MS (Zhou et al., 2017), and is 
similar in size and structure to LRP1 (Spuch et al., 2012).  However, we found no evidence of 
LRP2 expression in oligodendrocyte lineage cells in the healthy brain of control or Lrp1-deleted 
mice.   
As OPC differentiation can trigger OPC proliferation in vivo (Hughes et al., 2013), LRP1 could 
also have a secondary effect on OPC proliferation by influencing OPC differentiation.  We 
found that the deletion of Lrp1 from OPCs in the healthy adult mouse brain was associated 
with the increased addition of new (YFP-labelled) OLs.  Furthermore, deleting Lrp1 from early 
postnatal OPCs in vitro had a significant effect on the number of OPCs that became MBP+ OLs, 
suggesting that LRP1 is a direct negative regulator of OPC differentiation.  These data appear 
to conflict with a previous study, that indicated that the expression of Myrf, Mbp and CNPase 
mRNA was equivalent in OPCs cultured from the cortex of early postnatal Olig1-Cre  and Olig1-
Cre :: Lrp1fl/fl mice (Fernandez-Castaneda et al., 2019).  This discrepancy may be the result of 
our quantifying protein expression instead of gene expression, examining differentiation over 
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72 rather than 48 hours, or deleting Lrp1 immediately prior to differentiation, rather than in 
utero.  However, if Lrp1-deletion has a similar effect in vivo, leading to enhanced OPC 
differentiation, it could readily stimulate the homeostatic division of OPCs, increasing OPC 
proliferation to maintain a stable pool of progenitor cells (Hughes et al., 2013).   
 
4.3.2 LRP1 is a negative regulator of adult oligodendrogenesis 
 
New OLs are added to the adult mouse CNS throughout life (Dimou et al., 2008; Rivers et al., 
2008; Kang et al., 2010b; Zhu et al., 2011), however, when we followed the fate of adult OPCs 
after Lrp1 deletion, we observed a significant increase in the number of new OLs added to the 
corpus callosum and motor cortex within 30 and 45 days of gene deletion.  By contrast, 
deleting Lrp1 from cells of the OL lineage in the developing mouse (Olig2-Cre :: Lrp1fl/fl) has 
been shown to reduce the number of OLs detected in the optic nerve and result in 
hypomyelination by P21 (Lin et al., 2017).  This phenotype was attributed to a role for LRP1 in 
promoting cholesterol homeostasis and peroxisome function, and consequently 
developmental OPC differentiation (Lin et al., 2017).  Differences in the developing and adult 
brain environments (Velez-Fort et al., 2010), or changes in gene expression between 
developmental and adult OPCs (Spitzer et al., 2019) could account for LRP1 promoting 
developmental OPC differentiation, but suppressing adult OPC differentiation.  However, our 
in vitro data suggest that LRP1 can suppress the differentiation of developmental OPCs 
derived from the mouse cortex.  As deleting Lrp1 from neural stem and progenitor cell reduces 
the ability of these cells to generate cells of the OL lineage (Hennen et al., 2013; Safina et al., 
2016), and Olig2 can be expressed by murine radial glia and transiently expressed by neonatal 
astrocytes (Marshall et al., 2005; Cai et al., 2007), it is also possible that the developmental 
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deletion of Lrp1 from Olig2+ cells includes its deletion from some neural stem or progenitor 
cells during development, and limits the generation of OLs, impairing myelination.   
In the adult mouse brain, Lrp1-deleted OPCs produced a larger number of YFP+ OLs for the 
corpus callosum and motor cortex than Lrp1-intact OPCs.  However, YFP does not reveal the 
full morphology of the cell, so that it is not possible to determine whether Lrp1 regulated the 
number of newly formed pre-myelinating OLs and / or the number of new mature OLs that 
contributed myelin to the CNS.  In the healthy adult mouse brain, there is a significant 
population of pre-myelinating OLs (Xiao et al., 2016; Fard et al., 2017) that are constantly 
turned over, as ~78% of newly generated pre-myelinating OLs survive less than 2 days (Hughes 
et al., 2018).  By instead performing lineage tracing, visualising the newly generated OLs using 
LE-Pdgfra-CreERT2 :: Tau-mGFP mouse line, we confirmed that Lrp1-deletion was associated 
with an overall increase in new OL number.  However, as the proportion of new YFP+ 
oligodendrocytes that were pre-myelinating and myelinating oligodendrocytes was 
equivalent in the context of healthy adult control and Lrp1-deleted mice, LRP1 appears to 
increase the overall number but not the rate at which new OLs mature.  Furthermore, LRP1 
does not influence the myelinating profile of resulting mature OLs in the healthy CNS.   
4.3.3 LRP1 suppresses remyelination in the cuprizone-model of demyelination 
 
As Lrp1-deletion increased OPC differentiation, we predicted that Lrp1-deletion would also 
enhance the ability of OPCs to generate new OLs in response to a demyelinating injury.  
However, we instead found that the generation of new OLs from parenchymal OPCs was 
unaffected by LRP1 expression following cuprizone administration.  As cuprizone-
demyelination itself robustly stimulates OPC differentiation (Xing et al., 2014; Baxi et al., 
2017), it is possible that this repair response masks the effect of LRP1 on oligodendrogenesis.  
Alternatively, the discrepancy between the effect of Lrp1-deletion in health and following 
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injury may be explained by demyelination triggering new OPC generation from neural stem 
cells in the SVZ.  During cuprizone administration, a significant proportion of SVZ-derived OPCs 
enter the corpus callosum and contribute to oligodendrogenesis (Xing et al., 2014).  Within 
the corpus callosum of Lrp1-deleted mice, the migration of SVZ-derived OPCs results in a 
mixed population of LRP1+ and LRP1-negative OPCs, which may limit the stimulatory effect of 
Lrp1-deletion on OPC differentiation.  However, this seems unlikely, as Lrp1-deletion 
increased the number of new OLs added to the cortex of healthy adult LE-Lrp1-deleted mice, 
despite the presence of a mixed population of LRP1+ and LRP1-negative OPCs, resulting from 
the lower recombination efficiency observed in these mice.       
Following cuprizone-induced demyelination, we determined that both the number of 
parenchymal OPC-derived YFP+ OLs and the total number of OLs in the corpus callosum was 
equivalent for control and Lrp1-deleted mice.  However, the Lrp1-deleted mice showed a 
marked reduction in the proportion of the corpus callosum that was demyelinated.  While this 
could be explained by a difference in the behaviour or pre-existing, surviving OLs contributing 
more new myelin sheaths, as has been described to occur in humans (Yeung et al., 2019) this 
is unlikely as the vast majority of OLs detected in the corpus callosum were newborn EdU+ 
cells.  It is more likely that the reduced lesion size results from a change in the rate of 
maturation of the adult-born OLs, such that a larger proportion of them are already 
myelinating in the corpus callosum of Lrp1-deleted mice.  A separate study has found that 3.5 
days following cuprizone withdrawal, Olig1-Cre :: Lrp1fl/fl mice have more OLs and increased 
MBP coverage in the corpus callosum relative to Olig1-Cre controls (Fernandez-Castaneda et 
al., 2019).  As parenchymal OPCs and neural stem cell-derived OPCs all lack LRP1 in this model, 
these data support our finding that LRP1-expression by OPCs impacts remyelination.  
However, the expression of LRP1 by OPCs is unlikely to directly affect the maturing OLs, as OLs 
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still lack LRP1 even following demyelination.  It is more likely that LRP1 expression by OPCs 
indirectly regulates new born OL maturation within the injury environment.   
Neuroinflammation has long been associated with impaired OL generation (Miron et al., 
2011), and more recently OPCs have been identified as key modulators of the 
neuroinflammatory environment due to their ability to upregulate and express genes 
associated with antigen processing and presentation  (Falcao et al., 2018; Kirby et al., 2019). 
Furthermore, expression of a key immunomodulatory receptor on OPCs, the Interleukin 17 
receptor, was reported to be critical for EAE development, as it initiated cytokine release and 
propagated the pathology (Wang et al., 2017).  RNA profiling of the remyelinating corpus 
callosum of Olig1-Cre and Olig1-Cre :: Lrp1fl/fl mice 3.5 days after cuprizone withdrawal 
revealed that inflammatory gene expression was suppressed in the environment containing 
Lrp1-deleted OPCs (Fernandez-Castaneda et al., 2019).  As LRP1 expression by OPCs influences 
the inflammatory nature of the remyelinating environment, the enhanced remyelination we 
observe in Lrp1-deleted mice may reflect the level of influence that inflammation can exert 
on myelin repair in control versus Lrp1-deleted mice.    
It is currently unclear how LRP1 expression by OPCs influences inflammation within the 
remyelinating corpus callosum, however, LRP1 could be cleaved from OPCs or result in their 
secretion of pro-inflammatory factors that then influence the function of other cell types.  For 
example, when purified shed LRP1 (sLRP1) was added to microglia in vitro it induced a potent 
pro-inflammatory response (Brifault et al., 2017).  Furthermore, Lrp1 deletion from microglia 
in vivo significantly attenuated microglial activation and pro-inflammatory cytokine 
expression in the spinal dorsal horn following partial sciatic nerve ligation (Brifault et al., 
2019).  In light of these findings, it is possible that LRP1 shedding from OPCs may be acting on 
nearby microglia, amplifying inflammation within the local environment and impairing timely 
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remyelination.  Alternatively, LRP1 may influence antigen presentation by OPCs, influencing 
the activity of other inflammatory cells (Fernadez-Castaneda et al., 2019).  Therefore, while 
LRP1 appears to perform a cell-autonomous role in promoting OPC differentiation in the 
healthy brain, its role following demyelination appears to be more complex, and will require 
further research to fully elucidate the mechanism by which LRP1 expression by OPCs 
































Chapter 5 – Final Discussion and Future Directions 
 
Data presented in this thesis indicate that, consistent with microarray and RNA sequencing 
studies (Cahoy et al., 2008; Zhang et al., 2014), LRP1 is expressed by a number of CNS cell 
types throughout development and in adulthood, including neurons, astrocytes and microglia, 
however, LRP1 is not expressed by parvalbumin-expressing interneurons (Chapter 3).  Within 
the OL lineage, LRP1 is expressed by OPCs and rapidly downregulated as OPCs differentiate 
into OLs (Chapter 3).  Furthermore, in the healthy adult CNS, LRP1 acts to suppress 
oligodendrogenesis, as a larger number of newborn OLs are derived from Lrp1-deleted OPCs 
compared to control OPCs (Chapter 4).  Of the newborn OLs produced over a 30 day period, 
there was no change in the proportion of mature OLs compared to premyelinating OLs, 
suggesting that OPCs that lack Lrp1 mature at the same rate as control OPCs.   While LRP1 
does influence the number of myelinating OLs, by analysing individual newborn myelinating 
OLs, we determined that LRP1 did not influence the myelin load of individual cells, having no 
impact on the number or length of internodes they ultimately elaborate (Chapter 4).  By 
contrast, following cuprizone-induced demyelination of the corpus callosum, Lrp1-deletion 
did not affect the number of new OLs generated, but did reduce the area of the corpus 
callosum that was demyelinated, suggesting that LRP1 expression by OPCs acts (presumably 
indirectly) to reduce the maturation of or myelination by newborn OLs in an inflammatory 
environment (Chapter 4).  
 




Having shown that LRP1 inhibits oligodendrocyte generation in the healthy adult CNS, I 
wanted to look at its role in the demyelinated CNS.  I found that lesion area was reduced in 
Pdgfra-CreERT2 ::Rosa-26YFP :: Lrp1fl/fl mice following cuprizone administration compared to 
controls, however, surprisingly there was no associated increase in oligodendrogenesis 
(Chapter 4).  This suggests that the newborn OLs are able to mature more quickly and 
remyelinate more efficiently in the Lrp1-deleted mice following cuprizone administration.  
Visualisation of newly formed premyelinating and mature myelinating OLs in the remyelinated 
region would answer the question of enhanced maturation of Lrp1 deficient OPCs.   
OL maturation could be visualised using the LE-control and LE- Lrp1-del mice. However, this is 
unlikely to be successful a high level of recombination is needed to evaluate the effect of Lrp1 
deletion, and this will also result in GFP labelling of a large number of newborn callosal OLs 
precluding  the visualisation of isolated OL for morphological analysis.  An alternate approach 
would be to further analyse control and Lrp1 deleted mice, examining expression of specific 
markers that label premyelinating OLs such, as BCAS1 or Enpp6 for in situ hybridisation 
detection.  
 
One downside to using the inducible Pdgfra-CreERT2 :: Lrp1fl/fl mouse is that the new SVZ-
derived OPCs born during cuprizone administration expressed intact LRP1, creating a mixed 
population of LRP1+ and Lrp1-negative OPCs within the corpus callosum.  Other studies looking 
at the role of LRP1 in oligodendrocyte lineage cells did not have this problem as they were 
using a constitutively active Olig1-Cre or Olig2-Cre mouse. However, this ultimately means 
that Lrp1 is deleted from oligodendrocyte lineage cells throughout development, making it 
difficult to look specifically at LRP1 function during adulthood.  One way to eliminate the 
influence of SVZ-derived OPCs would be to repeat the experiments using the EAE model of 
 82 
neuroinflammation.  EAE primarily effects the spinal cord and the contribution of NSPCs to 
OPC addition and remyelination is minimal (Maeda et al., 2019).  
 
5.2 LRP1 as an inflammatory mediator 
 
The immunomodulatory role of OPCs is an emerging area of research (Falcao et al., 2018; Kirby 
et al., 2019) and it would be interesting to better understand the role that LRP1 plays in 
regulating the inflammatory response.  A previous study has proposed that in a demyelinated 
environment, LRP1 is required for the internalisation of antigen which leads to processing and 
cross presentation via MHC1 and subsequent activation of CD8 lymphocytes, exacerbating the 
inflammatory response (Fernandez-Castaneda et al., 2019).  The upregulation of antigen 
presenting molecules on OPCs following cuprizone would be interesting to visualise 
immunohistochemically but would be difficult to observe due to the increased activation of 
microglia.  Isolating OPCs in vitro and adding conditioned medium containing myelin debris 
and inflammatory cytokines may provide a better way to visualise antigen presentation.  
Additionally, it would be interesting to see whether OPCs that lack LRP1 are able to participate 
in antigen presentation as effectively as control OPCs.  Another intriguing aspect of LRP1 
signalling is the formation of soluble LRP1 (sLRP1) following cleavage of the extracellular 
domain (Quinn et al., 1999; Arnim et al., 2005). sLRP1 can be found in plasma and CSF and is 
upregulated following LPS exposure as well as in patients with rheumatoid arthritis (Liu et al., 
2009; Yamamoto et al., 2017). In myeloid cells, proteolytic shedding of LRP1 is thought to be 
a key step in the conversion of LRP1 from an anti-inflammatory to a pro-inflammatory 
molecule (Gorovoy et al., 2010; Brifault et al., 2017).  There is currently no evidence to show 
that LRP1 can be shed from OPCs but if something in the demyelinated environment is causing 
LRP1 to be released from OPCs then it may contribute to the level of neuroinflammation.  
Testing this on OPCs should be quite simple, as previous studies have shown that the addition 
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of LPS to cultured microglia is sufficient to stimulate the release of sLRP1 (Brifault et al., 2017).  
Following on from that, it would be interesting to look at the overall level of microglial 
activation and the presence of inflammatory cytokines in the corpus callosum of control and 
Lrp1-deleted mice after cuprizone administration. If there is an observable difference, it may 
be due to impaired antigen presentation and/or reduced shedding of LRP1 from OPCs, 
creating an environment that is more accommodating to remyelination.   
 
5.3 How does LRP2 contribute to MS pathology? 
 
The possibility of compensation from other LDL family receptors was thought to contribute to 
the delayed generation of a phenotype following Lrp1 deletion.  This hypothesis was 
strengthened by the discovery of a mutation in Lrp2 that led to an increased risk of developing 
relapse in people with MS (Zhou et al., 2017).  However, when looking in the CNS of control 
and Lrp1-deleted mice, I found no evidence that LRP2 was expressed by OPCs or OLs, 
suggesting that the mutation found in people with MS is unlikely to affect cells of the 
oligodendrocyte lineage (Chaper 4). I did however find that LRP2 is highly expressed by IBA1+ 
microglia and, to my knowledge, this is the first time that LRP2 has been shown to be 
expressed by these cells.  This discovery opens up a number of questions relating to its 
potential role in MS progression and warrants further investigation. LRP2 is most widely 
known for its in renal function but it is also a significant player in neural development due to 
its role in facilitating the endocytosis of Shh (Christ et al., 2012).  In the injured and inflamed 
CNS, upregulation of Shh has been shown to promote neural repair (Bambakidis et al., 2003; 
Amankulor et al., 2009) and silence the immune system in mice with EAE (Alvarez et al., 2011).  
As activated microglia are abundant in actively demyelinating lesions (Mycko et al., 2003; Sun 
et al., 2006), it is possible that deficiencies in Shh signalling result from an Lrp2 gene mutation 
and may worsen demyelination, leading to increased occurrence of relapse. A follow up study 
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deleting Lrp2 specifically from microglia using a Cx3cr1-CreERT2 :: Lrp2fl/fl mice prior to the 
induction EAE or cuprizone induced demyelination may uncover a novel role of microglial LRP2 
signalling in the demyelinated CNS.  
 
5.4 Conclusion  
 
By deleting LRP1 from OPCs in the adult CNS, this thesis builds upon the growing body of 
evidence that outlines the genes involved in regulating OPC behaviour in the healthy adult 
CNS.  Further studies are needed in order to determine how LRP1 alters the behaviour of OPCs 
in an inflammatory environment and ultimately determine whether the inhibition of LRP1  






























Primer Name Sequence 
LRP1 5' CATAC CCTCT CAAACC CCTT CCTG  
 
LRP1 3' GCAAG CTCC CTGCTCA GACC TGGA  
 
Cre 5' CAGGT CTCAG GAGCT ATGTC CAATT TACTG ACCGTA 
 
Cre 3' GGTGT TATAAG CAATCC CCAGAA 
 
Rosa26 5' WT AAAGT CGCTC TGAGT TGTTA 
 
Rosa26 5' Mut GCGAA GAGTT TGTCC TCAACC 
 
Rosa26 3' WT GGAGC GGGAG AAATG GATATG 
 
GFP 5' CCCTG AAGTTC ATCTG CACCAC 
 
GFP 3' TTCTC GTTGG GGTCT TTGCTC 
 
LRP1 reco 5' CCCAA GGAAAA TCAGG CCTCCGC 
 




Antibodies for immunofluorescence  
 
Antibody Species Concentration Manufacturer Catalogue Number 
LRP1 Rabbit 1:1000 Abcam AB92544 
PDGFRα Goat 1:100 R&D Systems AF1062 
PSANCAM Mouse 1:500 Millipore MAB5324 
RC2 Mouse 1:100 Millipore MAB5740 
GFAP Mouse 1:2000 BD Pharmigen 556327 
IBA1 Guinea Pig 1:250 Synaptic Systems 234004 
CC1 Mouse 1:200 Millipore MABC200 
NeuN Mouse 1:200 Millipore MAB337 
GFP Rat 1:2000 Nacalitesque 04404-26  
OLIG2 Rabbit 1:400 Millipore AB9610  
Parvalbumin Mouse 1:1000 Millipore MAB1572 
LRP2  Rabbit  1:100 Abcam  AB76967 
 
 
Cell culture medium  
 
OPC medium (50ml) Volume Final Conc. 
DMEM ~44ml - 
PDGF-AA 20µl 20ng/ml 
FGF 5µl 10ng/ml 
CNTF 25µl 10ng/ml 
NAC 50µl 5µg/ml 
NT3 5µl 1ng/ml 
Biotin 10µl 1ng/ml 
Forskolin 25µl 10µM 
10X SATO Stock  5ml 1X 
Pen/Strep 500µl 1X 
B27 1ml 2% 
 
SATO Stock  
 
10X SATO Stock (100ml)   Final Conc 
Transferrin 100mg 1mg/ml 
BSA 100mg 1mg/ml 
Progesterone (1mg/ml in EtOH) 60µl 600ng/ml 
Sodium selenite 1mg/ml in 0.1M NaOH) 40µl 400ng/ml 
Putrescine 16mg 160µg/ml 







OPC differentiation medium 
 
Differentiation medium 
(50ml) Volume Final Conc. 
DMEM ~44ml - 
T3 66µl  4µg/ml 
FGF 5µl 10ng/ml 
CNTF 25µl 10ng/ml 
NAC 50µl 5µg/ml 
NT3 5µl 1ng/ml 
Biotin 10µl 1ng/ml 
Forskolin 25µl 10µM 
10X SATO Stock  5ml 1X 
Pen/Strep 500µl 1X 






RIPA cell lysis buffer 
 
RIPA Buffer (10ml) Volume Final Conc 
MilliQ  8190μl - 
1M Tris-HCl (pH7.4) 500μl 50mM 
5M NaCl 300μl 150mM 
10% NP-40 1ml 1% 
Sodium deoxycholate 100mg 1% 
10% SDS 10μl 0.10% 
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